<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Genome Med</journal-id>
    <journal-id journal-id-type="iso-abbrev">Genome Med</journal-id>
    <journal-title-group>
      <journal-title>Genome Medicine</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1756-994X</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8127495</article-id>
    <article-id pub-id-type="publisher-id">904</article-id>
    <article-id pub-id-type="doi">10.1186/s13073-021-00904-z</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Liuyang</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Balmat</surname>
          <given-names>Thomas J.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Antonia</surname>
          <given-names>Alejandro L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Constantine</surname>
          <given-names>Florica J.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Henao</surname>
          <given-names>Ricardo</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Burke</surname>
          <given-names>Thomas W.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ingham</surname>
          <given-names>Andy</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>McClain</surname>
          <given-names>Micah T.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tsalik</surname>
          <given-names>Ephraim L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ko</surname>
          <given-names>Emily R.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ginsburg</surname>
          <given-names>Geoffrey S.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>DeLong</surname>
          <given-names>Mark R.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shen</surname>
          <given-names>Xiling</given-names>
        </name>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Woods</surname>
          <given-names>Christopher W.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hauser</surname>
          <given-names>Elizabeth R.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0113-5981</contrib-id>
        <name>
          <surname>Ko</surname>
          <given-names>Dennis C.</given-names>
        </name>
        <address>
          <email>dennis.ko@duke.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Department of Molecular Genetics and Microbiology, School of Medicine, </institution><institution>Duke University, </institution></institution-wrap>0049 CARL Building Box 3053, 213 Research Drive, Durham, NC 27710 USA </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Duke Research Computing, </institution><institution>Duke University, </institution></institution-wrap>Durham, NC 27710 USA </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Center for Applied Genomics and Precision Medicine, Department of Medicine, </institution><institution>Duke University, </institution></institution-wrap>Durham, NC 27710 USA </aff>
      <aff id="Aff4"><label>4</label>Durham Veterans Affairs Health Care System, Durham, NC 27705 USA </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.189509.c</institution-id><institution-id institution-id-type="ISNI">0000000100241216</institution-id><institution>Division of Infectious Diseases, Department of Medicine, </institution><institution>Duke University Medical Center, </institution></institution-wrap>Durham, NC 27710 USA </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.461399.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0441 0429</institution-id><institution>Department of Hospital Medicine, </institution><institution>Duke Regional Hospital, </institution></institution-wrap>Durham, NC 27705 USA </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Department of Biomedical Engineering, Woo Center for Big Data and Precision Health, </institution><institution>Duke University, </institution></institution-wrap>Durham, NC 27710 USA </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.189509.c</institution-id><institution-id institution-id-type="ISNI">0000000100241216</institution-id><institution>Duke Molecular Physiology Institute and Department of Biostatistics and Bioinformatics, </institution><institution>Duke University Medical Center, </institution></institution-wrap>Durham, NC 27710 USA </aff>
      <aff id="Aff9"><label>9</label>Cooperative Studies Program Epidemiology Center-Durham, Durham VA Health Care System, Durham, NC 27705 USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>17</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>13</volume>
    <elocation-id>83</elocation-id>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>1</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>5</day>
        <month>5</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">While genome-wide associations studies (GWAS) have successfully elucidated the genetic architecture of complex human traits and diseases, understanding mechanisms that lead from genetic variation to pathophysiology remains an important challenge. Methods are needed to systematically bridge this crucial gap to facilitate experimental testing of hypotheses and translation to clinical utility.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">Here, we leveraged cross-phenotype associations to identify traits with shared genetic architecture, using linkage disequilibrium (LD) information to accurately capture shared SNPs by proxy, and calculate significance of enrichment. This shared genetic architecture was examined across differing biological scales through incorporating data from catalogs of clinical, cellular, and molecular GWAS. We have created an interactive web database (interactive Cross-Phenotype Analysis of GWAS database (iCPAGdb)) to facilitate exploration and allow rapid analysis of user-uploaded GWAS summary statistics. This database revealed well-known relationships among phenotypes, as well as the generation of novel hypotheses to explain the pathophysiology of common diseases. Application of iCPAGdb to a recent GWAS of severe COVID-19 demonstrated unexpected overlap of GWAS signals between COVID-19 and human diseases, including with idiopathic pulmonary fibrosis driven by the <italic>DPP9</italic> locus. Transcriptomics from peripheral blood of COVID-19 patients demonstrated that <italic>DPP9</italic> was induced in SARS-CoV-2 compared to healthy controls or those with bacterial infection. Further investigation of cross-phenotype SNPs associated with both severe COVID-19 and other human traits demonstrated colocalization of the GWAS signal at the <italic>ABO</italic> locus with plasma protein levels of a reported receptor of SARS-CoV-2, CD209 (DC-SIGN). This finding points to a possible mechanism whereby glycosylation of CD209 by <italic>ABO</italic> may regulate COVID-19 disease severity.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Thus, connecting genetically related traits across phenotypic scales links human diseases to molecular and cellular measurements that can reveal mechanisms and lead to novel biomarkers and therapeutic approaches. The iCPAGdb web portal is accessible at <ext-link ext-link-type="uri" xlink:href="http://cpag.oit.duke.edu">http://cpag.oit.duke.edu</ext-link> and the software code at <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link>.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13073-021-00904-z.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Pleiotropy</kwd>
      <kwd>Cross-phenotype association</kwd>
      <kwd>Gout</kwd>
      <kwd>LD-score</kwd>
      <kwd>Colocalization</kwd>
      <kwd>PheWAS</kwd>
      <kwd>Hi-HOST</kwd>
      <kwd>Idiopathic pulmonary fibrosis</kwd>
      <kwd>Macular telangiectasia</kwd>
      <kwd>rs2869462</kwd>
      <kwd>rs505922</kwd>
      <kwd>rs12610495</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id>
            <institution>National Institute of Allergy and Infectious Diseases</institution>
          </institution-wrap>
        </funding-source>
        <award-id>R21AI133305</award-id>
        <award-id>R01AI118903</award-id>
        <principal-award-recipient>
          <name>
            <surname>Ko</surname>
            <given-names>Dennis C.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000185</institution-id>
            <institution>Defense Advanced Research Projects Agency</institution>
          </institution-wrap>
        </funding-source>
        <award-id>W911NF1920111</award-id>
        <principal-award-recipient>
          <name>
            <surname>Woods</surname>
            <given-names>Christopher W.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>Â© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par4">Genome-wide association studies (GWAS) have identified hundreds of thousands of genomic regions that are associated with complex human traits and have increased our understanding of the genetic architecture of human disease [<xref ref-type="bibr" rid="CR1">1</xref>]. While GWAS now utilize even millions of subjects through leveraging electronic medical record data [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], progress towards understanding how identified genetic variants alter cellular function and physiology remains elusive. More efficient mechanisms are needed for translating knowledge of genetic disease risk and severity into insight of the underlying physiology. Integrating analysis of GWAS across different scales of biological phenotypes (molecular, cellular, and organismal) may provide novel insight into how genetic variants influence complex traits.</p>
    <p id="Par5">Comparative analyses of GWAS have revealed that numerous, seemingly unrelated traits are connected by shared underlying genetic variants [<xref ref-type="bibr" rid="CR1">1</xref>]. This phenomenon in which genetic variants affect multiple traits or diseases is called pleiotropy. Several methods have been developed to study pleiotropic SNPs by exploring the genetic relationship of multiple phenotypes. Broadly, these approaches can be categorized into three major groups. The first method is genetic correlation, which aims to quantify the similarity of the genetic effects on pairwise traits using GWAS summary statistics such as LD-score regression [<xref ref-type="bibr" rid="CR4">4</xref>] or from individual genotype data with GCTA GREML [<xref ref-type="bibr" rid="CR5">5</xref>]. With large population sizes, these methods can accurately partition variance into a shared genetic component but do not reveal the genetic variants driving the genetic correlation. Genome-wide cross-trait analysis [<xref ref-type="bibr" rid="CR6">6</xref>] has emerged as a means to follow-up such results, but these univariate meta-analyses of two traits requires genome wide summary statistics for both traits, can suffer from effect size heterogeneity in combining results from disparate traits, and cannot be easily applied to thousands of traits at once. The second approach is colocalization, which estimates how well the GWAS signals from two signals overlap in a given region while revealing plausibility of individual causal variants [<xref ref-type="bibr" rid="CR7">7</xref>]. These two methods have successfully identified novel genetic connections across distant traits as well as pleiotropic genomic regions but have generally been used independently of each other. Finally, perhaps the most intuitive approach, is quantifying cross-phenotype SNPs that are shared across multiple phenotypes. In its simplest form, a phenome-wide association study takes a single SNP and examines the significance of association across many traits, often from electronic medical record [<xref ref-type="bibr" rid="CR8">8</xref>]. Valuable websites, including PhenoScanner [<xref ref-type="bibr" rid="CR9">9</xref>], GRASP [<xref ref-type="bibr" rid="CR10">10</xref>], and GeneATLAS [<xref ref-type="bibr" rid="CR11">11</xref>], have integrated thousands of GWAS studies with billions of SNP-traits associations and allow users to query individual SNPs across the phenome. However, such PheWAS approaches do not leverage shared genetic architecture that extends beyond individual SNPs and do not take advantage of LD information.</p>
    <p id="Par6">Motivated to simultaneously connect human phenotypes with shared genetic architecture and to identify the precise loci driving this similarity, we previously developed a method, CPAG (Cross-phenotype Analysis of GWAS), which estimated phenotype similarity of NHGRI-EBI GWAS catalog [<xref ref-type="bibr" rid="CR12">12</xref>] traits based on shared genetic associations [<xref ref-type="bibr" rid="CR13">13</xref>]. CPAG utilized cross-phenotype SNP associations to cluster traits into groups that were consistent with pre-defined categories and discovered novel pleiotropic SNPs connecting Crohnâs disease and the fatty acid palmitoleic acid. However, CPAG could not scale sufficiently to keep up with the massive increase in the scope and scale of GWAS (facilitated through increasing use of electronic medical record (EMR)-based GWAS of huge cohorts) and the deeper phenotyping of molecular and cellular traits that can provide insight into mechanisms of pathophysiology of disease. Here, we introduce iCPAGdb (interactive Cross-Phenotype Analysis of GWAS database; <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>]), a new cross-phenotype analysis platform with improved identification of shared loci using pre-computed ancestry-specific LD databases and a more efficient algorithm for capturing cross-phenotype associations. These improvements facilitated integration of the NHGRI-EBI GWAS catalog with large datasets of plasma and urine metabolites and cellular host-pathogen traits. Such integration of pleiotropic analyses using GWAS datasets that include intermediate traits across biological scales are crucial for moving from lists of associated SNPs to understanding the pathophysiology of complex diseases. Finally, iCPAGdb allows users to upload their own GWAS summary statistics via web interface (<ext-link ext-link-type="uri" xlink:href="http://cpag.oit.duke.edu">http://cpag.oit.duke.edu</ext-link>) to identify and explore shared SNPs between their own GWAS and a deep catalog of 4418 molecular, cellular, and disease phenotypes. Using a GWAS of severe COVID-19 [<xref ref-type="bibr" rid="CR15">15</xref>] as the querying phenotype in iCPAGdb revealed shared SNPs associated with idiopathic pulmonary fibrosis and plasma protein levels of CD209, a possible receptor for SARS-CoV-2.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <sec id="Sec3">
      <title>Collection of GWAS summary statistics</title>
      <p id="Par7">Publicly available GWAS summary statistics were downloaded from the following sources: 3793 traits from NHGRI-EBI GWAS Catalog (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/gwas/">https://www.ebi.ac.uk/gwas/</ext-link>) [<xref ref-type="bibr" rid="CR12">12</xref>] (version 1.02, downloaded on 2020/08/05), 79 traits from H2P2 cellular GWAS (<ext-link ext-link-type="uri" xlink:href="http://h2p2.oit.duke.edu">http://h2p2.oit.duke.edu</ext-link>) [<xref ref-type="bibr" rid="CR16">16</xref>], and 546 traits from human blood circulating metabolites and urine metabolites GWAS (<ext-link ext-link-type="uri" xlink:href="http://metabolomics.helmholtz-muenchen.de/gwas/">http://metabolomics.helmholtz-muenchen.de/gwas/</ext-link>) [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. NHGRI-EBI GWAS catalog traits included annotation by Experimental Factor Ontology (EFO). All GWAS data were harmonized to genome coordinates of HG19. In total, we collected 4418 GWAS traits, and 91,323 trait-SNPs pairs. A detailed list of trait-SNP pairs at varying <italic>p</italic> value threshold can be found in Table <xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>A summary of GWAS data in iCPAGdb</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Type</th><th>Traits/diseases #</th><th>SNPs (<italic>p</italic> &lt; 5eâ8)</th><th>Trait-SNP associations #</th><th>Website</th></tr></thead><tbody><tr><td>NHGRI catalog</td><td>Clinical GWAS</td><td>3793</td><td>63,933</td><td>85,639</td><td><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/gwas/">https://www.ebi.ac.uk/gwas/</ext-link></td></tr><tr><td>H2P2</td><td>Molecular/ cellular GWAS</td><td>79 (44 flow cytometric phenotypes +â35 cytokines)</td><td>17</td><td>3489 (<italic>p</italic> &lt; 1eâ5)</td><td><ext-link ext-link-type="uri" xlink:href="http://h2p2.oit.duke.edu">http://h2p2.oit.duke.edu</ext-link></td></tr><tr><td>Blood metabolites</td><td>Molecular GWAS</td><td>491 blood (453 metabolites +â38 xenobiotics)</td><td>1441</td><td>2024</td><td><ext-link ext-link-type="uri" xlink:href="http://metabolomics.helmholtz-muenchen.de/gwas/">http://metabolomics.helmholtz-muenchen.de/gwas/</ext-link></td></tr><tr><td>Urine metabolites</td><td>Molecular GWAS</td><td>55 urine</td><td>149</td><td>171</td><td><ext-link ext-link-type="uri" xlink:href="http://metabolomics.helmholtz-muenchen.de/gwas/">http://metabolomics.helmholtz-muenchen.de/gwas/</ext-link></td></tr><tr><td>Sum</td><td/><td>4418</td><td>65,540</td><td>91,323</td><td/></tr></tbody></table><table-wrap-foot><p>GWAS summary statistics were clumped to include only a lead SNP for each trait locus</p></table-wrap-foot></table-wrap></p>
      <p id="Par8">Severe COVID-19 summary statistics (adjusted for top 10 principal components) generated by Ellinghaus et al. [<xref ref-type="bibr" rid="CR15">15</xref>] were downloaded from the GRASP webpage of aggregated COVID-19 GWAS results (<ext-link ext-link-type="uri" xlink:href="https://grasp.nhlbi.nih.gov/Covid19GWASResults.aspx">https://grasp.nhlbi.nih.gov/Covid19GWASResults.aspx</ext-link>) [<xref ref-type="bibr" rid="CR10">10</xref>] (download date 2020/07/15). Genome coordinates were converted from GRCh38 to HG19 using UCSC liftOver. GWAS summary statistics of IPF were kindly provided by Allen et al. [<xref ref-type="bibr" rid="CR19">19</xref>] after requesting access from <ext-link ext-link-type="uri" xlink:href="https://github.com/genomicsITER/PFgenetics">https://github.com/genomicsITER/PFgenetics</ext-link>.</p>
    </sec>
    <sec id="Sec4">
      <title>LD clumping</title>
      <p id="Par9">GWAS summary statistics were individually pre-processed by LD clumping using <italic>PLINK v1.9</italic> [<xref ref-type="bibr" rid="CR20">20</xref>], based on genotypes from European populations from the 1000 Genomes project [<xref ref-type="bibr" rid="CR21">21</xref>]. The general PLINK command was â--clump-p1 1e-5 --clump-p2 1 --clump-r2 0.4 --clump-kb 1000.â For NHGRI/EBI GWAS catalog, the index SNPs were selected using the genome-wide significant <italic>p</italic> value threshold of 5âÃâ10<sup>â8</sup> (--clump-p1 5e-8). For molecular and cellular GWAS, we used a varying <italic>p</italic> value cutoff from 1âÃâ10<sup>â3</sup> to 1âÃâ10<sup>â5</sup> for --clump-p1 parameter to choose the index SNPs.</p>
      <p id="Par10">For uploaded GWAS data, iCPAGdb calls on PLINK automatically to perform LD clumping. Users can define the <italic>p</italic> value for --clump-p1 to select the index SNPs and choose proper LD structure (European, African, or Asian) based on the ancestry of the GWAS.</p>
    </sec>
    <sec id="Sec5">
      <title>LD proxy calculation</title>
      <p id="Par11">To maximize phenotypic associations due to indirect associations, pairwise LDÂ <italic>R</italic><sup>2</sup> values were computed for each leading SNP against its surrounding SNPs using the genotypes from the 1000 Genomes project (Phase 3 genotypes) [<xref ref-type="bibr" rid="CR21">21</xref>]. Prior to calculation, all SNPs with minor allele frequency less than 0.01 and missingness &gt;â0.1 were removed. <italic>R</italic><sup>2</sup>Â of pairwise SNPs within 10,000âbp windows were then calculated, and only LD proxies with R<sup>2</sup> &gt;â0.4 were retained in further analysis. The PLINK parameters for calculating LD were â--ld-window-kb 1000 --ld-window 10000 --keep-allele-order --r2 in-phase with-freqs gz.â The choice of <italic>R</italic><sup>2</sup> threshold of 0.4 was a practical decision made to reduce multiply counting regions with broad association signals in moderate LD, while maintaining sensitivity and specificity in detecting cross-phenotype associations. This <italic>R</italic><sup>2</sup> threshold was implemented in V1.0 of the iCPAGdb software used for all analysis in this manuscript and implemented in the web portal described below. However, users can also download the iCPAGdb V1.1 source code and population-specific LD proxy databases from Github (<ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>]) and run analysis with different <italic>R</italic><sup>2</sup> cutoffs to retain overlapping SNPs with higher LD (<italic>R</italic><sup>2</sup> &gt;â0.8) or lower LD (<italic>R</italic><sup>2</sup> &gt;â0.2). While performing colocalization analysis is a prudent subsequent step in pursuing any iCPAGdb results, we caution that this is especially true when using the <italic>R</italic><sup>2</sup> cutoff of 0.2, because the iCPAGdb analysis may be identifying two distinct association signals in the same region or a single shared signal being harder to detect due to noisy data.</p>
      <p id="Par12">Since GWAS may be performed on diverse populations from different ancestry or continents, we calculated ancestry-specific LD proxies for European, African, and Asian populations separately. European population included 503 samples from 5 populations (CEU, TSI, FIN, GBR, IBS), African included 661 samples from 7 populations (YRI, LWK, GWD, MSL, ESN, ASW, ACB), and Asian population included 504 samples from 5 populations (CHB, JPT, CHS, CDX, and KHV). We filtered genotypes for each ancestry population by minor allele frequency more than 0.01 and retained only biallelic SNPs. SNPs which have theÂ same genome coordinates were merged using â--merge-equal-pos.â For duplicated SNPs withÂ the same variant rsID, we kept only the first variant by using â--rm-dup force-firstâ using PLINK 2.0.</p>
    </sec>
    <sec id="Sec6">
      <title>Cross-phenotype SNP analysis</title>
      <p id="Par13">Cross-phenotype SNPs were used to quantify the similarity of different traits. Cross-phenotype loci were identified as leading SNPs and/or their LD proxies having statistically significant associations with more than one trait/disease. If two traits shared a common leading SNP, we termed this âdirect association.â If a leading SNP was associated with one trait, while its LD proxy SNPs were associated with another trait, we called this âindirect association.â If any shared SNP was in LD with another SNP with <italic>R</italic><sup>2</sup> &gt;â0.4, these SNPs were merged into a SNP block until no further LD was found across shared SNP/LD pairs. The similarity of traits pairs based on shared associated SNPs was quantified using the Chao-Sorensen and Jaccard similarity index as described [<xref ref-type="bibr" rid="CR13">13</xref>]. In this prior work, the Chao-Sorenson index resulted in clusters with less heterogeneity based on a pre-defined disease categorization compared to other measures of similarity and thus was the primary similarity index used in this work. The significance of association for each trait pair was calculated using Fisherâs exact test, based on the hypergeometric distribution:
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p=\frac{\left(\begin{array}{c}{n}_2\\ {}k\end{array}\right)\left(\begin{array}{c}{N}_e-{n}_2\\ {}{n}_1-k\end{array}\right)}{\left(\begin{array}{c}{N}_e\\ {}{n}_1\end{array}\right)} $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mfenced close=")" open="("><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/><mml:mi>k</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mrow><mml:mrow><mml:mfenced close=")" open="("><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>e</mml:mi></mml:msub><mml:mo>â</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>â</mml:mo><mml:mrow/><mml:mi>k</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mrow></mml:mrow><mml:mrow><mml:mfenced close=")" open="("><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mi>e</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="13073_2021_904_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par14">where <italic>N</italic><sub><italic>e</italic></sub> is the effective number of independent SNPs in the selected population, <italic>n</italic><sub>1</sub> and <italic>n</italic><sub>2</sub> are the number of independent SNPs associated with trait 1 and trait 2, and <italic>k</italic> is the number of independent SNP blocks. The effective number of independent SNPs for European, African and Asian population was obtained from Table 4 from [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
      <p id="Par15">The significance of associations for all trait pairs was further corrected for all possible pairwise comparisons using the Benjamini-Hochberg and Bonferroni methods for multiple test correction. A false discovery rate of 0.1 was chosen to identify significantly correlated trait pairs.</p>
    </sec>
    <sec id="Sec7">
      <title>Comparison to LDSC</title>
      <p id="Par16">Bulik-Sullivan et al. [<xref ref-type="bibr" rid="CR4">4</xref>] developed an innovative and unbiased method, LDSC, to estimate genetic correlation using GWAS summary statistics for all measured SNPs. Their model calculated the LD scores for a variant against all other variants in a 1 centimorgan window and hypothesized that SNPs with higher LD scores are tagged to a risk-conferring variant, and the genetic correlation among traits can be calculated by normalizing genetic covariance of SNP heritability. With this method, they estimated 276 genetic correlations for 24 diseases/traits based on full GWAS summary statistics [<xref ref-type="bibr" rid="CR23">23</xref>]. To evaluate the power of iCPAGdb, we calculated the genetic associations on the same 24 GWAS traits. For each trait pair, only SNPs associated with each trait passing a genome-wide significant threshold (5 Ã 10<sup>â8</sup>) were used by iCPAGdb. We quantified the strength of cross-phenotype similarity for each trait pair using the Chao-Sorensen similarity index. Since the <italic>p</italic> values from [<xref ref-type="bibr" rid="CR23">23</xref>] were not corrected by multiple test correction, we calculated the <italic>p</italic> values for <italic>r</italic><sub><italic>g</italic></sub>Â using the R â<italic>p.adjust</italic>â function with a total number of 276 comparisons.</p>
    </sec>
    <sec id="Sec8">
      <title>Colocalization analysis</title>
      <p id="Par17">To evaluate whether the associations of GWAS trait pairs identified by iCPAGdb were due to sharing the same causal variants, we performed colocalization analysis using the R COLOC packages [<xref ref-type="bibr" rid="CR7">7</xref>]. COLOC uses a Bayesian framework to estimate the posterior probability that two GWAS traits share two independent causal signals (PP3) or shares a single casual variant (PP4) in the selected genome region. For each trait pair evaluated by COLOC, SNPs within 200âkb window from the lead SNP were included. Since COLOC requires minor allele frequency (MAF) for each SNP in both GWAS studies, when MAF was not available, we calculated the MAF using European populations from the 1000 Genomes Project [<xref ref-type="bibr" rid="CR21">21</xref>]. We ran COLOC â<italic>coloc.abf</italic>â function using the default prior parameters, p1 = 1 Ã 10<sup>â4</sup>, p2 = 1 Ã 10<sup>â4</sup>, and p12 = 1 Ã 10<sup>â5</sup>. We also ran the built-in â<italic>sensitivity</italic>â function to evaluate the robustness of predefined priors, and all tests suggested that default prior parameters were robust. Therefore, we ran all colocalization analyses with default priors.</p>
    </sec>
    <sec id="Sec9">
      <title>COVID-19 transcriptomic analysis</title>
      <p id="Par18">Transcriptomics of COVID-19 peripheral blood was generated by a previous study as described [<xref ref-type="bibr" rid="CR24">24</xref>]. For that study [<xref ref-type="bibr" rid="CR24">24</xref>], samples were collected as part of the Molecular and Epidemiological Study of Suspected Infection (MESSI), which was conducted at Duke University Health System (DUHS) and the Durham Veterans Affairs Health Care System (DVAHCS). SARS-CoV-2 RT-PCR testing was used to confirm infection status. A total of 46 subjects were analyzed, 14 of which were assayed at more than 1 time point. In total, 77 samples were assayed. Subjects were divided into early (â¤ 10âdays), middle (11â21âdays), and late (&gt;â21âdays) stage based on duration of symptoms. Participant self-reported symptoms were recorded at each time point for 39 symptom categories. Each symptom was scored on a scale of 0â4, with 0 indicating not present, 1 mild, 2 moderate, 3 severe, and 4 very severe symptoms. Daily symptom severity (sum of symptom scores for all symptoms) was determined for each time point. At enrollment (day 0), date of symptom onset was determined, and an initial symptom survey recorded maximum score for each symptom category between symptom onset and study enrollment. Samples used for blood transcriptomics of acute respiratory infection due to seasonal coronavirus, influenza, or bacterial pneumonia, and healthy controls were also previously described [<xref ref-type="bibr" rid="CR24">24</xref>]. Total RNA was extracted from peripheral whole blood, and cDNA libraries prepared using NuGEN Universal Plus mRNA-seq with AnyDeplete Globin reduction were sequenced on the Illumina NovaSeq 6000, as described [<xref ref-type="bibr" rid="CR24">24</xref>]. In brief, STAR v 2.7.1 [<xref ref-type="bibr" rid="CR25">25</xref>] was used to align the short reads and generate the count matrix. The count matrix was further normalized using TMM method [<xref ref-type="bibr" rid="CR26">26</xref>] and log2 transformed. Associations were performed with generalized linear models (LIMMA, [<xref ref-type="bibr" rid="CR27">27</xref>]) and corrected for multiple testing using the Benjamini-Hochberg method [<xref ref-type="bibr" rid="CR28">28</xref>]. RNAs-seq datasets generated in [<xref ref-type="bibr" rid="CR24">24</xref>] are publicly available through the National Center for Biotechnology Information Gene Expression Omnibus, accession# GSE161731. For the present study, analysis of <italic>DPP9</italic> expression in these data was carried out in R, and <italic>p</italic> values were calculated using the Wilcoxon rank-sum test.</p>
    </sec>
    <sec id="Sec10">
      <title>iCPAGdb software and website implementation</title>
      <p id="Par19">iCPAGdb is comprised of two core parts, the back-end computation and the front-end web browser. All code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>]. The back-end was written in python v3.6 with utilization of SQLite. SQLite tables were constructed for harmonized GWAS datasets and LD tables for different populations and are accessed using python sqlite3 package. The GWAS table stores clumped GWAS summary statistics, including trait name, trait sources, SNP rsIDs, beta values, standard error/standard deviation of beta, effective allele, and <italic>p</italic> values. The ancestry-specific LD proxy tables contain pairwise SNPsâ rsID and <italic>R</italic><sup>2</sup> values (<italic>R</italic><sup>2</sup> &gt; = 0.4) for different populations. All SQLite tables were indexed on unique combinations of SNP and trait or SNP pairs for LD proxy tables, which greatly reduces the searching time. To further increase calculation speed, the core cross-phenotype analysis part of iCPAGdb is parallelized by utilizing multiple threads.</p>
      <p id="Par20">Primary software components for the web portion of iCPAGdb are the R statistical programming language [<xref ref-type="bibr" rid="CR29">29</xref>], the R package Shiny (v1.5.0) for interaction of web pages with R scripts [<xref ref-type="bibr" rid="CR30">30</xref>], Shiny Server as a 24/7 multi-user platform to make Shiny apps publicly accessible [<xref ref-type="bibr" rid="CR31">31</xref>], the database environment SQLite for efficient querying of GWAS and iCPAGdb results [<xref ref-type="bibr" rid="CR32">32</xref>], and the R package RSQLite to execute SQL queries from within R scripts [<xref ref-type="bibr" rid="CR33">33</xref>]. The results of a iCPAGdb execution are read by the R script, processed, and presented to the viewer in various tables and graphs on a web page. The iCPAGdb website is currently loaded with associations across more than 4400 public GWAS datasets that can be browsed and searched in âReviewâ mode. The user requests an existing iCPAGdb result set from which a corresponding table and heatmap are generated and displayed. Various filtering and graph construction controls are available for iterative sub-setting of data and selection of significance measure and number of top significant phenotype pairs to plot. The âDownload" button enables the researcher to make a local copy of records appearing in the currently displayed results table. Important packages used in this mode are DT for construction of and interaction with tables and ggplot2, plotly, and heatmaply for basic plotting, interactive plotting (hover labels), and heatmap generation, respectively. The web browser also allows users to upload their own GWAS summary data, and iCPAGdb will automatically perform LD clumping based on selected population and generate an atlas of connections for the userâs GWAS against &gt;â4400 GWAS traits in the database. In this âUploadâ mode, the user browses files on a local computer, selects a properly formatted GWAS result file of interest (containing, for a single phenotype, SNP rsIDs and GWAS <italic>p</italic> values), specifies format and column configuration, then uploads the file. Next, iCPAGdb computation parameter values, including iCPAGdb GWAS set to be crossed with, significance thresholds for filtering, and linkage disequilibrium (LD) population are specified. When âCompute CPAG" is pressed, the R script composes a system level command to execute the CPAG (Python) function. The future() function of the R future package [<xref ref-type="bibr" rid="CR34">34</xref>] combined with a delaying pipe from the promises package execute iCPAGdb operations asynchronously, waiting on completion before resuming R script execution. Typical run time for a single uploaded GWAS that is already clumped to lead variants is &lt;â30âs. For GWAS summary statistics including all SNPs in a study, run time is typically &lt;â2âmin. The results are available with downloadable tables and figures. Additional information on webapp is in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Results</title>
    <sec id="Sec12">
      <title>iCPAGdb: an atlas for discovery of cross-phenotype associations</title>
      <p id="Par21">We created iCPAGdb to facilitate exploration of cross-phenotype associations of human phenotypes and discovery of shared genetics connecting traits that were previously not known to be related. iCPAGdb utilizes 85,639 SNP-trait associations (<italic>p</italic> &lt;â5 Ã 10<sup>â8</sup>) across 3793 traits from the NHGRI-EBI GWAS catalog, incorporates additional GWAS datasets (see below and Table <xref rid="Tab1" ref-type="table">1</xref>), and allows for uploading and analysis of user GWAS summary statistics (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a). In contrast, the original CPAG (published in 2015 [<xref ref-type="bibr" rid="CR13">13</xref>];) used only 14198 SNP-trait associations for 887 traits from the NHGRI-EBI GWAS catalog.
<fig id="Fig1"><label>Fig. 1</label><caption><p>An improved method for finding shared genetic architecture of human traits. <bold>a</bold> The overall framework of the iCPAGdb pipeline. GWAS summary statistics (from published GWAS datasets or from user-uploaded GWAS) undergo LD clumping to obtain a lead variant for each signal below a specified <italic>p</italic> value threshold. These SNPs are queried against an LD proxy database generated from 1000 Genomes African, Asian, or European population to identify cross-phenotype associations through direct overlap or LD proxy at <italic>R</italic><sup>2</sup>â&gt;â0.4. Significance of overlap for each trait pair was calculated using Fisherâs exact test. Outputs can be visualized/downloaded from the iCPAGdb web browser. <bold>b</bold> Comparison of the number of shared SNPs for each NHGRI-EBI GWAS catalog trait pair identified through direct overlap vs. both direct and indirect (LD-proxy) overlap. <bold>c</bold> iCPAGdb detected more significant cross-phenotypes associations than CPAG1 at FDR &lt;â0.1. Expansion of the NHGRI-EBI GWAS catalog and improvements in capturing by LD proxy in iCPAGdb fueled a large increase in detected cross-phenotype associations across human traits. Comparisons between CPAG1 and iCPAGdb on the same 2013 dataset are in Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S3. <bold>d</bold> Circle plot of cross-phenotype associations detected by iCPAGdb in the NHGRI-EBI GWAS catalog. After excluding compound phenotypes (phenotypes described by NHGRI-EBI GWAS catalog as &gt;â1 comma-separated phenotype in their ontology), a total of 1709 traits involved in a total of 53314 cross-phenotype associations were left. These were categorized into 17 EFO Parental groups. Inner ribbons link phenotypes connected by cross-phenotype associations with the width of ribbon corresponding to the number of cross-phenotype associations. The axis outside the circle represents the cumulative number of associations for each group vs all other groups. <bold>e</bold> Comparison of genetic correlation from LD score regression (LDSC) and the Chao-Sorensen similarity index implemented in iCPAG demonstrates significant correlation. The genetic correlation <italic>r</italic><sub><italic>g</italic></sub> of 24 diseases/trait were obtained from [<xref ref-type="bibr" rid="CR23">23</xref>]. Since Chao-Sorensen values are bounded from 0 to 1 and <italic>r</italic><sub><italic>g</italic></sub> ranges from â 1 to 1, we used the absolute value of <italic>r</italic><sub><italic>g</italic></sub> here. Colored * indicates significant trait-pair for LDSC, iCPAGdb, or both at false discovery rate of 0.1. <bold>f</bold> A model demonstrating how SNPs regulate uric acid levels to impact the development of kidney stones and gout. <bold>g</bold> Riverplot of gout cross-phenotype associations generated from iCPAGdb output shows mapped genes associated with gout by GWAS (left) connected with NHGRI-EBI GWAS phenotypes grouped into EFO categories (right; colors are different categories). Cross-phenotype associations include causal connections (such as uric acid levels), comorbid outcomes (such as kidney stones), and regulators of disease (such as alpha-1-antitrypsin levels)</p></caption><graphic xlink:href="13073_2021_904_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par22">Beyond this large expansion in traits and associations, we improved on the original CPAG algorithm by clumping GWAS data from each study (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S1), creating a database of LD values based on 1000 Genomes [<xref ref-type="bibr" rid="CR21">21</xref>], allowing selection of either European, African, or Asian LD structure, and efficiently capturing cross-phenotype associations that are driven by LD proxy (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). For each trait pair, iCPAGdb first selects the lead SNPs from all associated loci at a selected <italic>p</italic> value threshold (<italic>p</italic> &lt;â5 Ã 10<sup>â8</sup> was used for analysis of the NHGRI-EBI GWAS catalog; Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S1; Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S2). These lead SNPs are compared across the trait pair to count directly shared SNPs. For SNPs that are not directly shared, iCPAGdb then checks an LD database for overlap by LD proxy. For all directly or indirectly shared SNPs, iCPAGdb further forms them into bigger SNP blocks by recursively merging them until each SNP block has no LD proxy with <italic>R</italic><sup>2</sup> &gt; = 0.4 against all others. iCPAGdb improves memory efficiency with built-in functions connecting to SQL GWAS and LD proxy databases and improves computational efficiency and speed by utilizing multiple CPUs. For the NHGRI-EBI GWAS Catalog, the growth of GWAS findings and improvements of iCPAGdb over the previous version of CPAG led to a 27.7-fold increase in direct cross-phenotype associations and a 47.7-fold increase in indirect cross-phenotype associations, many of which would have been missed by the original CPAG algorithm (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c, d). Indeed, analyzing the 2013 NHGRI-EBI GWAS catalog with iCPAGdb had little effect on direct associations but increased indirect associations by 76% (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S3).</p>
      <p id="Par23">Results of iCPAGdb are consistent with results from the orthogonal approach of genetic correlation by LD score regression [<xref ref-type="bibr" rid="CR4">4</xref>]. Comparing the absolute values for genetic correlation of 24 phenotypes from [<xref ref-type="bibr" rid="CR23">23</xref>] against a similarity index quantifying the degree of shared SNPs in iCPAGdb revealed that the two are significantly correlated (<italic>p</italic> = 3.52âÃâ10<sup>â8</sup>; <italic>R</italic><sup>2</sup> = 0.14) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>e). Nearly all phenotypes (64 of 70) that showed significant correlation by LD score regression also demonstrated a significant excess of shared SNPs in iCPAGdb. The output of iCPAGdb provides the SNPs driving the similarity between the two phenotypes, facilitating follow-up studies. Interestingly, 61% of pairwise comparisons that had significant overlap based on iCPAGdb did not have significant genetic correlation based on LD score regression. For example, LD-score regression did not detect significant genetic correlation between LDL and HDL cholesterol measurements [<xref ref-type="bibr" rid="CR23">23</xref>], but iCPAGdb detected 92 shared SNPs, including 31 by direct overlap where the two phenotypes have the same lead SNPs (<italic>p</italic> = 7.55 Ã 10<sup>â195</sup> by Fisherâs exact test; <italic>p</italic> = 1.49 Ã 10<sup>â190</sup> after Benjamini-Hochberg procedure. <italic>p</italic> values from iCPAGdb in the remainder of the paper are FDR-corrected for all pairwise comparisons using Benjamini-Hochberg procedure). As iCPAGdb quantifies overlapping SNPs to detect shared genetic associations rather than genetic correlation based on genome-wide summary statistics, iCPAGdb may be detecting instances where discrete loci are shared (perhaps suggesting shared biology or pleiotropy), even though the genome-wide genetic correlation is weak. Another possibility is due to the fact that iCPAGdb does not take into account directionality of effects for quantifying SNP overlap. Shared SNPs with inconsistent direction of effect between traits can lead to overall low genetic correlation by LD score regression, even when many SNPs are shared, as has been previously described for some autoimmune diseases [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
    </sec>
    <sec id="Sec13">
      <title>GWAS of varying phenotypic scales reveals shared genetic architecture connecting molecular and cellular traits with human disease</title>
      <p id="Par24">In a previous study [<xref ref-type="bibr" rid="CR13">13</xref>], we defined 4 categories of cross-phenotype associations: (1) SNP similarity between an intermediate trait/risk factor and disease, (2) SNP similarity between a disease and a consequence of disease, (3) SNP similarity between two traits affected by the same gene/pathway, and (4) SNP similarity between two traits affected by the same gene having effects in different tissues or on different pathways. Of these categories, perhaps the most clinically useful is the first categoryâshared SNPs that connect an intermediate trait to a disease may reveal how molecular or cellular phenotypes mediate some aspect of the pathophysiology of disease. While the NHGRI-EBI GWAS catalog is comprised primarily of case-control GWAS of disease, we detected numerous known shared associations linking a human disease with levels of a metabolite. Metabolites are the substrates, intermediates, and products of cellular metabolism and are routinely already used as biomarkers, such as measuring glucose in diabetes management.</p>
      <p id="Par25">Cross-phenotype associations involving the metabolite uric acid and gout, an inflammatory arthritis driven by excess levels of uric acid [<xref ref-type="bibr" rid="CR35">35</xref>], are illustrative of iCPAGdbâs usefulness. GWAS studies have been conducted on risk of gout [<xref ref-type="bibr" rid="CR36">36</xref>â<xref ref-type="bibr" rid="CR43">43</xref>] as well as uric acid or urate levels [<xref ref-type="bibr" rid="CR44">44</xref>â<xref ref-type="bibr" rid="CR51">51</xref>]. Notably, of 32 GWAS loci for gout and 126 GWAS loci for serum uric acid levels at <italic>p</italic> &lt; 5 Ã 10<sup>â8</sup>, 13 loci overlap, including 9 loci identified only by LD proxy (over 5000-fold enrichment; <italic>p</italic> = 1.4 Ã 10<sup>â42</sup>). These loci are spread across 7 chromosomes and include several solute carrier (SLC) and ATP-binding class (ABC) transporters that control urate absorption and secretion. Some of the loci are in close proximity but are counted separately by iCPAGdb, as could occur if different GWAS studies locate nearby peaks that fall below our <italic>R</italic><sup>2</sup> &gt; 0.4 threshold or if multiple causal signals are located in the same region. These data provide genetic evidence for the well-known causal role of excess uric acid in gout and further reveal multiple genes that may serve as therapeutic targets. Inhibitors of renal uric acid reabsorption through URAT1 (<italic>SLC22A12</italic>) are commonly used in treating gout [<xref ref-type="bibr" rid="CR52">52</xref>], but additional transporters implicated through human genetics may also prove to be useful drug targets. Beyond uric acid levels, GWAS of kidney stones [<xref ref-type="bibr" rid="CR53">53</xref>â<xref ref-type="bibr" rid="CR55">55</xref>], a second manifestation of elevated uric acid levels, also share associated SNPs with gout (3 shared loci, all identified by proxy on chromosomes 2, 4, and 17; <italic>p</italic> = 5.9 Ã 10<sup>â9</sup>). Finally, gout shares 2 loci (out of 5 from [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]) with levels of serum alpha-1-antitrypsin, an anti-inflammatory endogenous protease inhibitor (<italic>p</italic> = 1.0 Ã 10<sup>â6</sup>), providing a human genetic rationale for the use of alpha-1-antitrypsin-based therapeutics in acute gouty flares (as has been demonstrated to be efficacious in mice [<xref ref-type="bibr" rid="CR58">58</xref>]). Thus, examining the gout cross-phenotype associations revealed causal connections, comorbid conditions with shared etiology, and factors that modulate inflammation in the disease (Fig. <xref rid="Fig1" ref-type="fig">1</xref>f, g).</p>
      <p id="Par26">Shared genetic associations reveal other well-known molecular and cellular disease relationships such as LDL cholesterol levels with cardiovascular disease (1.61 Ã 10<sup>â83</sup>) and Alzheimerâs disease (<italic>p</italic> = 8.9 Ã 10<sup>â17</sup>) as well as glucose with type II diabetes mellitus (<italic>p</italic> = 5.3 Ã 10<sup>â40</sup>). Other cross-phenotype associations highlight genetic variation that can extend our knowledge. For example, cross-phenotype associations were found between malaria [<xref ref-type="bibr" rid="CR59">59</xref>â<xref ref-type="bibr" rid="CR64">64</xref>] and red blood cell distribution width [<xref ref-type="bibr" rid="CR65">65</xref>â<xref ref-type="bibr" rid="CR69">69</xref>] (<italic>p</italic> = 1.4 Ã 10<sup>â9</sup>). This overlap is driven by well-known genetic variation in the beta-hemoglobin gene (<italic>HBB)</italic> and <italic>ABO</italic> blood type affecting malaria risk but also by genetic variation in <italic>ATP2B4</italic> which encodes a calcium transporter. To the best of our knowledge, whether size of red blood cells impacts susceptibility to malaria parasites has not been examined. These cross-phenotype associations demonstrate the promise of this approach for revealing novel relationships that can be mined through iCPAGdb.</p>
    </sec>
    <sec id="Sec14">
      <title>Expansion of iCPAGdb to additional datasets of molecular and cellular traits</title>
      <p id="Par27">The above examples of clinically relevant cross-phenotype associations involving metabolite and cellular phenotypes motivated expansion of iCPAGdb to additional datasets. We used three datasets to provide molecular and cellular traits to our analysis: 491 metabolites and xenobiotics in blood [<xref ref-type="bibr" rid="CR18">18</xref>] and 55 metabolites in urine [<xref ref-type="bibr" rid="CR17">17</xref>], both from the Metabolomics GWAS Server (<ext-link ext-link-type="uri" xlink:href="http://metabolomics.helmholtz-muenchen.de/gwas/index.php">http://metabolomics.helmholtz-muenchen.de/gwas/index.php</ext-link>), and 79 cellular host-pathogen interaction traits from our dataset of cellular host-pathogen interaction GWAS, H2P2 (<ext-link ext-link-type="uri" xlink:href="http://h2p2.oit.duke.edu">http://h2p2.oit.duke.edu</ext-link>) [<xref ref-type="bibr" rid="CR16">16</xref>]. iCPAGdb revealed many connections between these molecular/cellular datasets and the NHGRI-EBI GWAS catalog (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a; Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S2).
<fig id="Fig2"><label>Fig. 2</label><caption><p>iCPAGdb integrates GWAS of different scales to reveal a biological connection between MacTel 2 and serine. <bold>a</bold> Multi-dataset network of cross-phenotype associations detected by iCPAGdb. Phenotypes that demonstrated significant overlap (FDR â¤0.1) are color-coded in the indicated colors. <bold>b</bold> Riverplot of macular telangiectasia type 2 (MacTel type 2) cross-phenotype associations generated from iCPAGdb shows mapped genes associated with MacTel type 2 (left) connected with NHGRI-EBI GWAS phenotypes grouped into EFO categories (right; colors are different categories). SNPs in <italic>CPS1</italic> and <italic>PHGDH</italic> are associated with MacTel type 2 and are also associated with serine levels, which are believed to play a causal role in the disease. Other connections may represent causal connections, comorbid outcomes, and regulators of disease. <bold>c</bold> Cross-phenotype associations connecting MacTel type 2 and serine. One locus demonstrated direct SNP overlap (rs715). A second locus demonstrated indirect overlap based on 4 SNPs in LD as visualized in the heatmap color-coded by LD. <bold>d</bold> A model for how SNPs regulate serine levels to impact pathogenesis of MacTel type 2 based on iCPAGdb and prior work described in the text</p></caption><graphic xlink:href="13073_2021_904_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par28">Cross-phenotype associations with macular telangiectasia (MacTel) type 2, a disease characterized by loss of central vision due to alterations in blood vessels in the macula of the eye, confirmed the importance of the amino acid serine (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). A GWAS of MacTel type 2 uncovered 3 genome-wide significant loci and the authors noted that two of these loci were involved in serine/glycine metabolism, with the alleles associated with low glycine and serine conferring increased risk of MacTel type 2 [<xref ref-type="bibr" rid="CR70">70</xref>]. The authors speculated that the low serine levels could lead to high levels of ammonia and glutamate causing neurotoxicity and stress-induced angiogenesis [<xref ref-type="bibr" rid="CR70">70</xref>]. Gantner et al. have since provided evidence that low serine levels result in elevated levels of deoxysphingolipids to trigger cell death in photoreceptors [<xref ref-type="bibr" rid="CR71">71</xref>]. iCPAGdb rediscovered the connection of two loci being shared between serine in serum (measured by [<xref ref-type="bibr" rid="CR18">18</xref>]) and risk of MacTel (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c, d; <italic>p</italic> = 3.9 Ã 10<sup>â7</sup>; 99,084-fold enrichment). iCPAGdb also revealed 7 other serum metabolites including glycine that shared an association with rs715 but not with the second MacTel locus. While serine was not part of the urine metabolomics dataset, iCPAGdb did detect overlap of glycine in urine and MacTel type 2 (<italic>p</italic> = 0.01).</p>
      <p id="Par29">We also included host-pathogen traits from H2P2, a cellular GWAS we previously carried out using 528 lymphoblastoid cell lines (LCLs) exposed to 7 different pathogens [<xref ref-type="bibr" rid="CR16">16</xref>]. Notably, unlike the metabolomics datasets, H2P2 identified SNPs associated with traits at baseline and in response to stimuli. Further, as pathogens have likely been drivers of human evolution [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>], comparing H2P2 to human disease GWAS may reveal unintended consequences of past pandemics on the human genome. Previously, we reported colocalization of a locus regulating CXCL10 levels following <italic>Chlamydia trachomatis</italic> infection (rs2869462) and risk of inflammatory bowel disease [<xref ref-type="bibr" rid="CR16">16</xref>]. iCPAGdb revealed shared genetic variants for this H2P2 phenotype and blood levels of CXCL9 (MIG) [<xref ref-type="bibr" rid="CR74">74</xref>] (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a; <italic>p</italic> = 0.04). <italic>p</italic> values for the two associations are strongly correlated (Fig. <xref rid="Fig3" ref-type="fig">3</xref>b), and the effect size for SNPs associated with both chemokines are significantly positively correlated (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c). We utilized COLOC, which uses a Bayesian framework to determine whether GWAS signals in the same region are likely due to the same causal variant [<xref ref-type="bibr" rid="CR7">7</xref>]. The posterior probability that both CXCL10 protein levels from cells and CXCL9 levels in blood share the same causal variant is 0.90 (Table <xref rid="Tab2" ref-type="table">2</xref>), with rs2869462 identified as the most likely causal SNP (Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Table S3). The genes encoding these two chemokines are adjacent to each other on chromosome 4, and this result points to variants regulating expression of both genes that will make it challenging to disentangle their effects in disease.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Cross-phenotype association analysis reveals the same genetic locus impacts both <italic>Chlamydia</italic>-induced CXCL10 levels and MIG level in serum. <bold>a</bold> Regional Miami colocalization plot demonstrates a genetic locus that impacts both CXCL10 level in lymphoblastoid cell lines following <italic>Chlamydia trachomatis</italic> infection and CXCL9 (MIG) levels in serum. <bold>b</bold> Comparison of -log10(<italic>p</italic> value) for GWAS of CXCL10 following <italic>C. trachomatis</italic> infection and levels of CXCL9 (MIG) in serum. The lead SNP in the region for each phenotype is marked. <bold>c</bold> Scatter plot demonstrates a highly positive correlation of the effect coefficients of cellular CXCL10 after <italic>C. trachomatis</italic> infection and of SNPs associated with blood CXCL9 levels. Each dot represents a SNP which has <italic>p</italic> value &lt;â0.01 for both phenotypes. A total of 413 SNPs from a 4-mb window surrounding the leading SNP rs2869462 was selected. The blue vertical or red horizontal bar shows the standard error of the beta value for each SNP</p></caption><graphic xlink:href="13073_2021_904_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>COLOC analysis output</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Trait1</th><th>Trait2</th><th>Locus</th><th>SNP #</th><th>PP3</th><th>PP4</th><th>PP3 + PP4</th><th>PP4/PP3</th><th>Lead causal SNP</th></tr></thead><tbody><tr><td>CXCL10 level after <italic>Chlamydia</italic> infection</td><td>Blood CXCL9 levels</td><td>CXCL10</td><td>1533</td><td>0.101</td><td>0.899</td><td>1.00</td><td>8.91</td><td>rs2869462</td></tr><tr><td>COVID-19</td><td>Plasma CD209 antigen level</td><td>ABO</td><td>56</td><td>0.0159</td><td>0.984</td><td>1.00</td><td>61.72</td><td>rs505922</td></tr><tr><td>COVID-19</td><td>Idiopathic pulmonary fibrosis</td><td>DPP9</td><td>1233</td><td>0.00216</td><td>0.994</td><td>0.996</td><td>459.63</td><td>rs12610495</td></tr></tbody></table><table-wrap-foot><p>PP3 is the posterior probability for the model where the two traits have independent causal variants. PP4 is the posterior probability for the model where the two traits share a single causal variant</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec15">
      <title>Application of iCPAGdb to COVID-19 reveals susceptibility due to ABO may occur through regulation of CD209</title>
      <p id="Par30">We applied iCPAGdb to a recently published GWAS of severe COVID-19 with respiratory failure [<xref ref-type="bibr" rid="CR15">15</xref>]. While this study focused on two genome-wide significant associations at the <italic>ABO</italic> locus and in a cluster of chemokine receptors and other genes on Chromosome 3, we relaxed the <italic>p</italic> value threshold for iCPAGdb to 1âÃâ10<sup>â5</sup>, resulting in 24 suggestive loci after LD clumping. Not surprisingly, iCPAGdb revealed that the genome-wide significant association near the blood type locus <italic>ABO</italic> is in LD with multiple other SNPs in this region associated with other human diseases and traits (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a; Additional file <xref rid="MOESM8" ref-type="media">8</xref>: Table S4). This included the classic association with malaria resistance [<xref ref-type="bibr" rid="CR64">64</xref>], but also less well known associations with duodenal ulcer [<xref ref-type="bibr" rid="CR75">75</xref>], pancreatic cancer [<xref ref-type="bibr" rid="CR76">76</xref>], and heart failure [<xref ref-type="bibr" rid="CR77">77</xref>]. Multiple studies have now reported the association of the <italic>ABO</italic> locus with risk of COVID-19 [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. The causal effect on COVID-19 may involve A and B antigens on blood cells, antibodies against A and B antigens, the enzymatic activity of the ABO glycosyltransferase on possibly other glycoproteins, or even other genes in the region. Insight into these possible mechanisms was revealed by iCPAGdb, which identified association of this locus with levels of 8 individual proteins in the NHGRI-EBI GWAS catalog. These proteins, all encoded on different chromosomes than ABO, include IL-6, TNF-Î±, CD209 (DC-SIGN), Tie-1, mannose-binding protein C, FGF23, and clotting factors (factor VIII and vWF). In each of these cases, the association of the locus to both molecular trait and disease provides a plausible causal chain from SNP to <italic>cis</italic>-effect on <italic>ABO</italic> to trans-effect on a protein to severe COVID-19 disease. For example, association with VWF and Factor VIII may indicate ABO affects COVID-19 through regulation of thrombosis, as patients with severe COVID-19 can have thromboembolic complications as part of a hyper-inflammatory state [<xref ref-type="bibr" rid="CR79">79</xref>]. In fact, both VWF and factor VIII are targets of glycosylation by ABO [<xref ref-type="bibr" rid="CR80">80</xref>â<xref ref-type="bibr" rid="CR82">82</xref>] and levels of these proteins are reported to be regulated by ABO [<xref ref-type="bibr" rid="CR83">83</xref>â<xref ref-type="bibr" rid="CR87">87</xref>]. Further, regulation of levels of IL-6 and TNF-Î± suggest possible regulation of inflammation, as âcytokine stormâ plays an important role during severe COVID-19 [<xref ref-type="bibr" rid="CR88">88</xref>]. Most interestingly, the <italic>ABO</italic> locus is associated with both COVID-19 and CD209 (<italic>p</italic> = 0.008). A preprint recently confirmed this association across populations, and these authors speculated that ABO may affect CD209 levels to regulate SARS-CoV-2 entry [<xref ref-type="bibr" rid="CR89">89</xref>]. Indeed, there has since been evidence from two preprints that CD209 can bind to SARS-CoV-2 and can act as a receptor for entry into immune cells [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>].
<fig id="Fig4"><label>Fig. 4</label><caption><p>Cross-phenotype association of <italic>ABO</italic> reveals a possible role for CD209 in severe COVID-19. <bold>a</bold> A network of genetic associations involving severe COVID-19. Each node represents either a disease/trait (filled circles) or a gene (dark blue diamond). The <italic>ABO</italic> locus was associated with multiple other diseases and levels of specific proteins, while DPP9 connects COVID-19 only with IPF and interstitial lung disease (idiopathic interstitial pneumonia). <bold>b</bold> Regional Miami colocalization plot demonstrates the <italic>ABO</italic> locus impacts both CD209 protein levels and risk of severe COVID-19. <bold>c</bold> A significant positive correlation for effect size of SNPs in the <italic>ABO</italic> locus on CD209 protein levels and risk of severe COVID-19. <bold>d</bold> Model of how <italic>ABO</italic> may affect CD209 and severe COVID-19</p></caption><graphic xlink:href="13073_2021_904_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par31">The âAâ allele of rs657152 associated with increased risk of COVID-19 with respiratory failure is also associated with increased levels of CD209 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b). We performed colocalization analysis of the GWAS signals for COVID-19 [<xref ref-type="bibr" rid="CR15">15</xref>] and CD209 protein levels [<xref ref-type="bibr" rid="CR57">57</xref>]. This analysis indicated the two are likely driven by the same causal variants (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c; COLOC posterior probability PP4 = 0.98 with the lead causal SNP of rs505922; Additional file <xref rid="MOESM9" ref-type="media">9</xref>: Table S5). Thus, iCPAGdb and subsequent colocalization analysis support a model where <italic>ABO</italic> regulates CD209 protein levels to impact COVID-19 risk, though much future experimental and clinical studies will be required to fully test this hypothesis (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d). The pleiotropic effects of <italic>ABO</italic> on levels of multiple proteins will make defining the mechanism challenging.</p>
    </sec>
    <sec id="Sec16">
      <title>Application of iCPAGdb to COVID-19 reveals a role for DPP9 in regulation of both COVID-19 and idiopathic pulmonary fibrosis</title>
      <p id="Par32">Beyond <italic>ABO,</italic> a locus in the dipeptidyl peptidase 9 (<italic>DPP9</italic>) gene associated at <italic>p</italic> &lt; 1 Ã 10<sup>â5</sup> with severe COVID-19 was identified as being shared with a GWAS of fibrotic idiopathic interstitial pneumonia [<xref ref-type="bibr" rid="CR92">92</xref>] and a recent GWAS of the most severe form of that group of diseases, idiopathic pulmonary fibrosis (IPF) [<xref ref-type="bibr" rid="CR19">19</xref>]. rs12610495 was the lead variant for each of these GWAS studies as well as the suggestive peak for severe COVID-19 (<italic>p</italic> = 5.2 Ã 10<sup>â6</sup> [<xref ref-type="bibr" rid="CR15">15</xref>];). Much evidence has already accumulated that pulmonary fibrosis is a hallmark of severe COVID-19 [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]. While the association of rs12610495 with COVID-19 did not reach genome-wide significance in Ellinghaus et al. 2020 [<xref ref-type="bibr" rid="CR15">15</xref>], this SNP is in LD with the lead variant from a recent GWAS of critically ill COVID-19 patients that does surpass genome-wide significance (<italic>p</italic> = 3.98 Ã 10<sup>â12</sup> [<xref ref-type="bibr" rid="CR95">95</xref>];; <italic>R</italic><sup>2</sup> = 0.95 in 1000 Genomes European populations). Thus, iCPAGdb alerted us to the importance of a suggestive COVID-19 susceptibility locus that has since been validated in an independent cohort.</p>
      <p id="Par33">We determined that rs12610495 is an eQTL in lung tissue for the gene for <italic>DPP9</italic> (and no other genes in the region) in GTEx (<italic>p</italic> = 4.5 Ã 10<sup>â9</sup> [<xref ref-type="bibr" rid="CR96">96</xref>];)<italic>,</italic> with the âGâ allele being associated with lower expression (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a)<italic>.</italic> Interestingly, DPP9 is a protease in the same family as DPP4, the receptor for MERS-coronavirus [<xref ref-type="bibr" rid="CR97">97</xref>]. Additionally, DPP9 is an inhibitor of inflammasome activation by NLRP3 [<xref ref-type="bibr" rid="CR98">98</xref>â<xref ref-type="bibr" rid="CR100">100</xref>]. Colocalization analysis confirmed the signals from severe COVID-19 and IPF are likely driven by the same causal variant (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b; COLOC posterior probability PP4 = 0.994, lead SNP rs12610495; Additional file <xref rid="MOESM10" ref-type="media">10</xref>: Table S6). Based on these data and the known biology, we developed alternative hypotheses for how this SNP might be regulating risk of severe COVID-19: <italic>DPP9</italic> may be acting as a previously unrecognized receptor for SARS-CoV-2 or it may be inhibiting inflammation during COVID-19 infection. Based on the directionality of effect of rs12610495 on <italic>DPP9</italic> gene expression, the âGâ allele should lead to lower <italic>DPP9</italic> expression and less entry if the receptor model is correct. However, the âGâ allele is instead associated with increased risk of severe COVID-19 (Fig. <xref rid="Fig5" ref-type="fig">5</xref>c). Alternatively, the âGâ allele could lead to lower <italic>DPP9</italic> to increase inflammasome activation in lung tissue, a model consistent with âGâ increasing risk of severe COVID-19 and this allele also increasing risk of idiopathic pulmonary fibrosis (Fig. <xref rid="Fig5" ref-type="fig">5</xref>d).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Cross-phenotype analysis and COVID-19 patient transcriptomics reveals a role for <italic>DPP9</italic> in severe COVID-19. <bold>a</bold> Lung eQTL data from GTEx shows rs12610495 âGâ allele is associated with reduced expression of <italic>DPP9</italic>. <bold>b</bold> Regional Miami colocalization plot demonstrates the <italic>DPP9</italic> locus impacts both idiopathic pulmonary fibrosis and risk of severe COVID-19. <bold>c</bold> A significant positive correlation for effect size of SNPs in the <italic>DPP9</italic> locus on idiopathic pulmonary fibrosis and risk of severe COVID-19. <bold>d</bold> Model of how <italic>DPP9</italic> may affect idiopathic pulmonary fibrosis and risk of severe COVID-19. <bold>e</bold>
<italic>DPP9</italic> expression in peripheral blood is significantly higher in COVID-19 patients (<italic>n</italic> = 77Â samples) compared to healthy (<italic>n</italic> = 19) and bacteria-infected patients (<italic>n</italic> = 23). The <italic>p</italic> values were calculated using the Wilcoxon rank-sum test. <bold>f</bold> COVID-19 patients demonstrate significantly higher <italic>DPP9</italic> expression compared to healthy controls during early (days 1â10; <italic>n</italic> = 19 samples), middle (days 11â20;Â <italic>n</italic> = 36), and late (21+ days; n=22) stages of SARS-CoV-2 infection. The <italic>p</italic> values were calculated using the Wilcoxon rank-sum test. <bold>g</bold>
<italic>DPP9</italic> demonstrates increased expression during recovery from COVID-19. A total of 11 patients were measured sequentially at enrollment (day 0), day 7, and day 14. The colored dash line connects measurements from the same patient across time points. <italic>p</italic> value was calculated using Friedman test. <bold>h</bold> Decreased symptom severity scores of COVID-19 patients over time. The eleven subjects in G were assessed for symptom severity at days 0, 7, and 14. The colored dash line connects measurements from the same patient across time points. <italic>p</italic> value was calculated using Friedman test</p></caption><graphic xlink:href="13073_2021_904_Fig5_HTML" id="MO5"/></fig></p>
      <p id="Par34">To further examine the role of <italic>DPP9</italic> in COVID-19, we analyzed previously generated transcriptomics of peripheral blood from COVID-19 patients [<xref ref-type="bibr" rid="CR24">24</xref>]. Levels of <italic>DPP9</italic> expression across 46 COVID-19 patients were compared to individuals with seasonal coronavirus, influenza, bacterial pneumonia, and healthy controls. <italic>DPP9</italic> levels were significantly increased in COVID-19 patients compared to the other groups (fold-change = 1.15, <italic>p</italic> = 0.003 adjusted by Benjamini-Hochberg method). Comparing COVID-19 data vs. each comparator individually revealed that <italic>DPP9</italic> levels were elevated vs. healthy controls (<italic>p</italic> = 0.0016) and bacterial infection (<italic>p</italic> = 0.0078) but not influenza or other coronavirus infection (Fig. <xref rid="Fig5" ref-type="fig">5</xref>e). This data supports a role for <italic>DPP9</italic> in the host response to viral infections. In examining all samples in the cohort, increased <italic>DPP9</italic> was observed both early and late in COVID-19 infection (Fig. <xref rid="Fig5" ref-type="fig">5</xref>f). However, eleven subjects that did not require hospitalization had repeated measurements at day 0 (initial enrollment into the study), day 7, and day 14 that revealed changes in <italic>DPP9</italic> expression as infection resolved. While <italic>DPP9</italic> expression increased from day 0 compared to 7âdays and 14âdays (Fig. <xref rid="Fig5" ref-type="fig">5</xref>g; <italic>p</italic> = 0.0089), symptom severity dramatically improved over this period (Fig. <xref rid="Fig5" ref-type="fig">5</xref>h; <italic>p</italic> = 0.00006). We speculate that <italic>DPP9</italic> may be induced to effectively turn off the inflammatory response to SARS-CoV-2 to minimize tissue damage and fibrosis. Combined with our human genetic data, these findings suggest that insufficient induction of <italic>DPP9</italic> expression could predispose to severe COVID-19.</p>
    </sec>
    <sec id="Sec17">
      <title>Searching the iCPAGdb web server with user-provided GWAS summary statistics</title>
      <p id="Par35">As the above examples demonstrate, iCPAGdb analysis can rapidly generate hypotheses connecting molecular and cellular traits to human disease. The website allows quick access to the pre-calculated cross-phenotype associations results described in this manuscript. Users can also upload their own GWAS summary statistics for comparing against all 4418 GWAS traits in the iCPAGdb website, facilitating the discovery of new cross-phenotype relationships. Total time for uploading, clumping of summary statistics, and calculation of cross-phenotype associations is typically &lt;â2âmin.</p>
    </sec>
  </sec>
  <sec id="Sec18">
    <title>Discussion</title>
    <p id="Par36">The expansion of GWAS studies to more molecular, cellular, and human disease traits requires the development and implementation of new tools to facilitate drawing meaningful connections between phenotypes and understanding the molecular mechanisms that explain this shared genetic architecture. Our work demonstrates that leveraging available GWAS summary statistics and efficient algorithms of integrating pleiotropic information using ancestry-specific LD structure can rapidly reveal cross-phenotype associations across different phenotypic scales, which can be applied in real-time to better understand ongoing health crises such as the SARS-CoV2 pandemic.</p>
    <p id="Par37">In examining cross-phenotype connections, it is important to carefully examine the overlapping SNPs provided as part of the iCPAGdb output to determine (1) the genome location where the variants are located, as some may be adjacent/overlapping loci in weak LD and not truly distinct and (2) how well identified GWAS signals from two traits overlap. Indeed, we view iCPAGdb as the first step in a pipeline for gaining greater understanding of any GWAS that then moves to colocalization analysis (see Figs. <xref rid="Fig3" ref-type="fig">3</xref>a, <xref rid="Fig4" ref-type="fig">4</xref>b, <xref rid="Fig5" ref-type="fig">5</xref>b; Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Table S3; Additional file <xref rid="MOESM9" ref-type="media">9</xref>: Table S5; Additional file <xref rid="MOESM10" ref-type="media">10</xref>: Table S6), to further dissect GWAS signals in the same region. Making summary statistics more readily available for all GWAS, especially earlier studies in NHGRI-EBI GWAS, would facilitate these validation studies. Finally, functional studies in model systems and clinical studies are needed to test the proposed hypothesis and deeply understand the underlying mechanisms.</p>
    <p id="Par38">While the current web implementation of iCPAGdb uses NHGRI-EBI GWAS catalog [<xref ref-type="bibr" rid="CR12">12</xref>], H2P2 [<xref ref-type="bibr" rid="CR16">16</xref>], and metabolomics GWAS datasets [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], additional datasets of molecular, cellular, and disease GWAS can be easily added. Analysis of user-uploaded GWAS may be the most useful application of iCPAGdb and will lead to discovery of new connections among human phenotypes to encourage experimental and clinical follow-up studies. Our studies of COVID-19 provide a test case for this and revealed possible mechanisms underlying the associations of severe COVID-19 with <italic>ABO</italic> and <italic>DPP9.</italic></p>
    <p id="Par39">While our work highlights shared genetic architecture regulating <italic>ABO</italic>, protein abundance, and COVID-19, much work remains to be done to understand the mechanisms underlying these connections. The <italic>ABO</italic> locus controls abundance of many proteins. Some of these proteins, such as VWF and Factor VIII, have already been shown to be regulated by glycosylation of ABO [<xref ref-type="bibr" rid="CR80">80</xref>â<xref ref-type="bibr" rid="CR82">82</xref>]. For CD209, <italic>ABO</italic> is a protein quantitative trait locus, but it is unknown whether CD209 protein abundance is regulated by ABO glycosylation. CD209 has a predicted N-linked glycosylation site (N80) and glycosylation has been observed by mass spectrometry (<ext-link ext-link-type="uri" xlink:href="http://glycositeatlas.biomarkercenter.org/glycosites/33001/">http://glycositeatlas.biomarkercenter.org/glycosites/33001/</ext-link>) [<xref ref-type="bibr" rid="CR101">101</xref>]. Whether human genetic variation also impacts CD209 glycosylation is also an unanswered question. Previous studies have examined protein glycosylation as a GWAS trait, resulting in 16 genome-wide significant loci [<xref ref-type="bibr" rid="CR102">102</xref>â<xref ref-type="bibr" rid="CR104">104</xref>], 15 of which have been recently replicated [<xref ref-type="bibr" rid="CR105">105</xref>]. However, these studies quantified total plasma N-glycans released from proteins and did not specifically quantify glycosylation and glycoforms for individual proteins. Future GWAS quantifying individual glycosylated protein isoforms, as well as other post-translational modifications, may therefore be valuable.</p>
    <p id="Par40">The shared underlying genetic risk factors for IPF and COVID-19 suggest that <italic>DPP9</italic> may have a common role in pathogenesis in these diseases. iCPAGdb was able to identify this connection in the first published COVID19 GWAS despite the <italic>DPP9</italic> allele being below genome-wide significance in that cohort, demonstrating the utility of iCPAGdb in expanding the power of GWAS studies on emerging and understudied diseases. We speculate that characteristics of inflammasome-mediated responses, normally suppressed by high expression of <italic>DPP9</italic>, may predispose to fibrosis. The shared genetic architecture also suggests that therapeutic approaches targeting fibrosis may be beneficial in both conditions. Pirfenidone and Nintedanib are anti-fibrotic FDA-approved drugs used to treat IPF, and our findings support the idea that these drugs may prove beneficial in COVID-19 [<xref ref-type="bibr" rid="CR106">106</xref>â<xref ref-type="bibr" rid="CR108">108</xref>].</p>
  </sec>
  <sec id="Sec19">
    <title>Conclusions</title>
    <p id="Par41">As our examination of COVID-19 demonstrates, iCPAGdb is a powerful hypothesis engine that will lead to a deeper understanding of the genetic underpinnings of human disease risk, severity, and drug response.</p>
  </sec>
  <sec id="Sec20">
    <title>Availability and requirements</title>
    <p id="Par42">Project name: iCPAGdb</p>
    <p id="Par43">Project home page: <ext-link ext-link-type="uri" xlink:href="http://cpag.oit.duke.edu">http://cpag.oit.duke.edu</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>]</p>
    <p id="Par44">Operating system(s): Red Hat Enterprise Linux OS, v7.9</p>
    <p id="Par45">Programming language: Python v3.6 and R Shiny v1.5</p>
    <p id="Par46">Other requirements: PLINK v1.9; R packages: shiny, shinyjs, DT, RSQLite, ggplot2, heatmaply, plotly, future; Python packages: panda, scipy, joblib, tqdm, sqlite</p>
    <p id="Par47">License: GPL v3</p>
    <p id="Par48">Any restrictions to use by non-academics: No restriction for non-academic use</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec21">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13073_2021_904_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1.</bold> iCPAGdb Web App Supplement.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="13073_2021_904_MOESM2_ESM.pdf">
            <caption>
              <p><bold>Additional file 2: Figure S1.</bold> Clumping of GWAS results from NHGRI-EBI GWAS catalog.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="13073_2021_904_MOESM3_ESM.xlsx">
            <caption>
              <p><bold>Additional file 3: Table S1.</bold> iCPAGdb output for cross-phenotype associations from NHGRI-EBI GWAS catalog (downloaded on August 5, 2020).</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="13073_2021_904_MOESM4_ESM.pdf">
            <caption>
              <p><bold>Additional file 4: Figure S2.</bold> Histogram of shared SNPs for each trait pair in NHGRI-EBI GWAS catalog from iCPAGdb at false discovery rate of 0.1.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="13073_2021_904_MOESM5_ESM.pdf">
            <caption>
              <p><bold>Additional file 5: Figure S3.</bold> Comparison of CPAG1 and iCPAGdb using the NHGRI-EBI GWAS catalog summary statistics downloaded on September 4, 2013.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="13073_2021_904_MOESM6_ESM.xlsx">
            <caption>
              <p><bold>Additional file 6: Table S2.</bold> iCPAGdb output for cross-phenotype associations between molecular and cellular datasets and NHGRI-EBI GWAS catalog.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM7">
          <media xlink:href="13073_2021_904_MOESM7_ESM.xlsx">
            <caption>
              <p><bold>Additional file 7: Table S3.</bold> COLOC analysis of <italic>CXCL10</italic> following <italic>C. trachomatis</italic> infection and levels of <italic>CXCL9</italic> (MIG) in whole blood.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM8">
          <media xlink:href="13073_2021_904_MOESM8_ESM.xlsx">
            <caption>
              <p><bold>Additional file 8: Table S4.</bold> Cross-phenotype associations for COVID-19 (<italic>p</italic> value &lt;â1 Ã 10<sup>-5</sup>) against 4418 GWAS traits in iCPAGdb (<italic>p</italic> value &lt;â5 Ã 10<sup>-8</sup>).</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM9">
          <media xlink:href="13073_2021_904_MOESM9_ESM.xlsx">
            <caption>
              <p><bold>Additional file 9: Table S5.</bold> COLOC analysis output for <italic>ABO</italic> region between COVID-19 and CD209 antigen levels.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM10">
          <media xlink:href="13073_2021_904_MOESM10_ESM.xlsx">
            <caption>
              <p><bold>Additional file 10: Table S6.</bold> COLOC analysis output for <italic>DPP9</italic> region between COVID-19 and idiopathic pulmonary fibrosis.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisherâs Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We thank Benjamin Schott, Jeffrey Bourgeois, and Kyle Gibbs for thoughtful discussions. We thank Dr. Richard J. Allen and colleagues for sharing idiopathic pulmonary fibrosis GWAS summary statistics.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authorsâ contributions</title>
    <p>LW and DCK conceived of the study. LW, TJB, ERH, AI, MRD, ERH, and DCK developed iCPAGdb. LW, TJB, FJC, and RH carried out computational analysis. LW, ALA, and DCK analyzed iCPAGdb results. MTM, FJC, RH, TWB, XS, GSG, ELT, ERK, and CWW carried out the COVID-19 transcriptomics study and helped design subsequent analysis carried out by LW. All authors contributed to the manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>LW, TJB, AI, MRD, ERH, and DCK were supported by NIH R21AI133305. LW, ALA, and DCK were supported by NIH R01AI118903. FJC, RH, TWB, MTM, XS, ELT, ERK, and CWW were supported by DARPA/USMRAA W911NF1920111 and NIH UM1AI104681. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Web resources:</p>
    <p>iCPAGdb website: <ext-link ext-link-type="uri" xlink:href="http://cpag.oit.duke.edu">http://cpag.oit.duke.edu</ext-link></p>
    <p>iCPAGdb GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>]</p>
    <p>NHGRI GWAS Catalog: <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/gwas/">https://www.ebi.ac.uk/gwas/</ext-link> [<xref ref-type="bibr" rid="CR12">12</xref>]</p>
    <p>H2P2 cellular GWAS: <ext-link ext-link-type="uri" xlink:href="http://h2p2.oit.duke.edu">http://h2p2.oit.duke.edu</ext-link> [<xref ref-type="bibr" rid="CR16">16</xref>]</p>
    <p>Human metabolite GWAS summary statistics: <ext-link ext-link-type="uri" xlink:href="http://metabolomics.helmholtz-muenchen.de/gwas/index.php?task=download">http://metabolomics.helmholtz-muenchen.de/gwas/index.php?task=download</ext-link> [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]</p>
    <p>COVID-19 GWAS summary statistics from Ellinghaus et al. (2020) [<xref ref-type="bibr" rid="CR15">15</xref>] were downloaded from the GRASP webpage of aggregated COVID-19 GWAS results [<xref ref-type="bibr" rid="CR10">10</xref>]: <ext-link ext-link-type="uri" xlink:href="https://grasp.nhlbi.nih.gov/Covid19GWASResults.aspx">https://grasp.nhlbi.nih.gov/Covid19GWASResults.aspx</ext-link></p>
    <p>IPF GWAS: download link was obtained by applying for access following the collaborative protocol from <ext-link ext-link-type="uri" xlink:href="https://github.com/genomicsITER/PFgenetics">https://github.com/genomicsITER/PFgenetics</ext-link> [<xref ref-type="bibr" rid="CR19">19</xref>]</p>
    <p>RNA-seq datasets generated in [<xref ref-type="bibr" rid="CR24">24</xref>] are publicly available through the National Center for Biotechnology Information Gene Expression Omnibus, accession# GSE161731 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161731">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161731</ext-link></p>
    <p>Tools for visualization:</p>
    <p>R packages:</p>
    <p>ggplot2: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggplot2/">https://cran.r-project.org/web/packages/ggplot2/</ext-link> [<xref ref-type="bibr" rid="CR109">109</xref>]</p>
    <p>gggenes: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/gggenes/index.html">https://cran.r-project.org/web/packages/gggenes/index.html</ext-link> [<xref ref-type="bibr" rid="CR110">110</xref>]</p>
    <p>tidygraph: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/tidygraph/">https://cran.r-project.org/web/packages/tidygraph/</ext-link> [<xref ref-type="bibr" rid="CR111">111</xref>]</p>
    <p>ggnetwork: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggnetwork/">https://cran.r-project.org/web/packages/ggnetwork/</ext-link> [<xref ref-type="bibr" rid="CR112">112</xref>]</p>
    <p>circlize: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/circlize/">https://cran.r-project.org/web/packages/circlize/</ext-link> [<xref ref-type="bibr" rid="CR113">113</xref>]</p>
    <p>ggpubr: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggpubr/">https://cran.r-project.org/web/packages/ggpubr/</ext-link> [<xref ref-type="bibr" rid="CR114">114</xref>]</p>
    <p>DT: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/DT">https://cran.r-project.org/web/packages/DT</ext-link> [<xref ref-type="bibr" rid="CR115">115</xref>]</p>
    <p>plotly: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/plotly/">https://cran.r-project.org/web/packages/plotly/</ext-link> [<xref ref-type="bibr" rid="CR116">116</xref>]</p>
    <p>heatmaply: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/heatmaply/">https://cran.r-project.org/web/packages/heatmaply/</ext-link> [<xref ref-type="bibr" rid="CR117">117</xref>]</p>
    <p>promises: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=promises">https://CRAN.R-project.org/package=promises</ext-link> [<xref ref-type="bibr" rid="CR118">118</xref>]</p>
    <p>All iCPAGdb output described in this manuscript are available for browsing from <ext-link ext-link-type="uri" xlink:href="http://cpag.oit.duke.edu">http://cpag.oit.duke.edu</ext-link>. Supplemental files also contain iCPAGdb output and COLOC analysis results. Code is available at GitHub <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par49">Not applicable</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par50">Not applicable</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par51">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Visscher</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Wray</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>MA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>10âyears of GWAS discovery: biology, function, and translation</article-title>
        <source>Am J Hum Genet.</source>
        <year>2017</year>
        <volume>101</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.06.005</pub-id>
        <?supplied-pmid 28686856?>
        <pub-id pub-id-type="pmid">28686856</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bycroft</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Petkova</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Band</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Elliott</surname>
            <given-names>LT</given-names>
          </name>
          <name>
            <surname>Sharp</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Motyer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vukcevic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Delaneau</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>OâConnell</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cortes</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Welsh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Effingham</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>McVean</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Leslie</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Donnelly</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Marchini</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The UK Biobank resource with deep phenotyping and genomic data</article-title>
        <source>Nature.</source>
        <year>2018</year>
        <volume>562</volume>
        <issue>7726</issue>
        <fpage>203</fpage>
        <lpage>209</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-018-0579-z</pub-id>
        <?supplied-pmid 30305743?>
        <pub-id pub-id-type="pmid">30305743</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCarty</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Chisholm</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Chute</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Kullo</surname>
            <given-names>IJ</given-names>
          </name>
          <name>
            <surname>Jarvik</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Larson</surname>
            <given-names>EB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies</article-title>
        <source>BMC Med Genomics.</source>
        <year>2011</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>13</fpage>
        <pub-id pub-id-type="doi">10.1186/1755-8794-4-13</pub-id>
        <?supplied-pmid 21269473?>
        <pub-id pub-id-type="pmid">21269473</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bulik-Sullivan</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Loh</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Finucane</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Ripke</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <collab>Schizophrenia Working Group of the Psychiatric Genomics C</collab>
          <etal/>
        </person-group>
        <article-title>LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title>
        <source>Nat Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <issue>3</issue>
        <fpage>291</fpage>
        <lpage>295</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3211</pub-id>
        <pub-id pub-id-type="pmid">25642630</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Goddard</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Visscher</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Wray</surname>
            <given-names>NR</given-names>
          </name>
        </person-group>
        <article-title>Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood</article-title>
        <source>Bioinformatics.</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>19</issue>
        <fpage>2540</fpage>
        <lpage>2542</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts474</pub-id>
        <?supplied-pmid 22843982?>
        <pub-id pub-id-type="pmid">22843982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Anttila</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Smoller</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>PH</given-names>
          </name>
        </person-group>
        <article-title>Statistical power and utility of meta-analysis methods for cross-phenotype genome-wide association studies</article-title>
        <source>PLoS One.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>3</issue>
        <fpage>e0193256</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0193256</pub-id>
        <?supplied-pmid 29494641?>
        <pub-id pub-id-type="pmid">29494641</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giambartolomei</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vukcevic</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Schadt</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Franke</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hingorani</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Plagnol</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Bayesian test for colocalisation between pairs of genetic association studies using summary statistics</article-title>
        <source>PLoS Genet.</source>
        <year>2014</year>
        <volume>10</volume>
        <issue>5</issue>
        <fpage>e1004383</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1004383</pub-id>
        <?supplied-pmid 24830394?>
        <pub-id pub-id-type="pmid">24830394</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Denny</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Ritchie</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Basford</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Pulley</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Bastarache</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Brown-Gentry</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations</article-title>
        <source>Bioinformatics.</source>
        <year>2010</year>
        <volume>26</volume>
        <issue>9</issue>
        <fpage>1205</fpage>
        <lpage>1210</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq126</pub-id>
        <pub-id pub-id-type="pmid">20335276</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Staley</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Blackshaw</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kamat</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Ellis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Surendran</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Paul</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Freitag</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Burgess</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Danesh</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Butterworth</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>PhenoScanner: a database of human genotype-phenotype associations</article-title>
        <source>Bioinformatics.</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>20</issue>
        <fpage>3207</fpage>
        <lpage>3209</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btw373</pub-id>
        <?supplied-pmid 27318201?>
        <pub-id pub-id-type="pmid">27318201</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leslie</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>O'Donnell</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>AD</given-names>
          </name>
        </person-group>
        <article-title>GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database</article-title>
        <source>Bioinformatics.</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>12</issue>
        <fpage>i185</fpage>
        <lpage>i194</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu273</pub-id>
        <?supplied-pmid 24931982?>
        <pub-id pub-id-type="pmid">24931982</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Canela-Xandri</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Rawlik</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tenesa</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>An atlas of genetic associations in UK Biobank</article-title>
        <source>Nat Genet.</source>
        <year>2018</year>
        <volume>50</volume>
        <issue>11</issue>
        <fpage>1593</fpage>
        <lpage>1599</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0248-z</pub-id>
        <?supplied-pmid 30349118?>
        <pub-id pub-id-type="pmid">30349118</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buniello</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>MacArthur</surname>
            <given-names>JAL</given-names>
          </name>
          <name>
            <surname>Cerezo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>LW</given-names>
          </name>
          <name>
            <surname>Hayhurst</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Malangone</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D1005</fpage>
        <lpage>D1D12</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id>
        <?supplied-pmid 30445434?>
        <pub-id pub-id-type="pmid">30445434</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oehlers</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Espenschied</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Rawls</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Tobin</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Ko</surname>
            <given-names>DC</given-names>
          </name>
        </person-group>
        <article-title>CPAG: software for leveraging pleiotropy in GWAS to reveal similarity between human traits links plasma fatty acids and intestinal inflammation</article-title>
        <source>Genome Biol.</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>190</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-015-0722-1</pub-id>
        <?supplied-pmid 26374098?>
        <pub-id pub-id-type="pmid">26374098</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Wang L, Balmat T, Ko DC. iCPAGdb: GitHub; 2021. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/tbalmat/iCPAGdb">https://github.com/tbalmat/iCPAGdb</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <mixed-citation publication-type="other">Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al. Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med. 2020;383:1522â34.</mixed-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Pittman</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Barker</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Salinas</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Stanaway</surname>
            <given-names>IB</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>GD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An atlas of genetic variation linking pathogen-induced cellular traits to human disease</article-title>
        <source>Cell Host Microbe.</source>
        <year>2018</year>
        <volume>24</volume>
        <issue>2</issue>
        <fpage>308</fpage>
        <lpage>323</lpage>
        <pub-id pub-id-type="doi">10.1016/j.chom.2018.07.007</pub-id>
        <pub-id pub-id-type="pmid">30092202</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raffler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Friedrich</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Arnold</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kacprowski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Rueedi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Altmaier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bergmann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Budde</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gieger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Homuth</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pietzner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>RÃ¶misch-Margl</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Strauch</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>VÃ¶lzke</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Waldenberger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wallaschofski</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nauck</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>VÃ¶lker</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>KastenmÃ¼ller</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Suhre</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association study with targeted and non-targeted NMR metabolomics identifies 15 novel loci of urinary human metabolic individuality</article-title>
        <source>PLoS Genet.</source>
        <year>2015</year>
        <volume>11</volume>
        <issue>9</issue>
        <fpage>e1005487</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1005487</pub-id>
        <?supplied-pmid 26352407?>
        <pub-id pub-id-type="pmid">26352407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Fauman</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Krumsiek</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Santos</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An atlas of genetic influences on human blood metabolites</article-title>
        <source>Nat Genet.</source>
        <year>2014</year>
        <volume>46</volume>
        <issue>6</issue>
        <fpage>543</fpage>
        <lpage>550</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2982</pub-id>
        <?supplied-pmid 24816252?>
        <pub-id pub-id-type="pmid">24816252</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allen</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Guillen-Guio</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Oldham</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Dressen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Paynton</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Kraven</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Obeidat</surname>
            <given-names>M'</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Braybrooke</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Molina-Molina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hobbs</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Putman</surname>
            <given-names>RK</given-names>
          </name>
          <name>
            <surname>Sakornsakolpat</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Booth</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Fahy</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Hart</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Hirani</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hubbard</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>McAnulty</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Millar</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Navaratnam</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Oballa</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Parfrey</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Saini</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Whyte</surname>
            <given-names>MKB</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kaminski</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Adegunsoye</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Strek</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Neighbors</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sheng</surname>
            <given-names>XR</given-names>
          </name>
          <name>
            <surname>Gudmundsson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gudnason</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Hatabu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lederer</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Manichaikul</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Newell</surname>
            <given-names>JD</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>OâConnor</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Ortega</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fingerlin</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>BossÃ©</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Joubert</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nickle</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Sin</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Timens</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Furniss</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Zondervan</surname>
            <given-names>KT</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>IP</given-names>
          </name>
          <name>
            <surname>Sayers</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Tobin</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Maher</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Hunninghake</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Yaspan</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Molyneaux</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Flores</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Noth</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>Wain</surname>
            <given-names>LV</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis</article-title>
        <source>Am J Respir Crit Care Med.</source>
        <year>2020</year>
        <volume>201</volume>
        <issue>5</issue>
        <fpage>564</fpage>
        <lpage>574</lpage>
        <pub-id pub-id-type="doi">10.1164/rccm.201905-1017OC</pub-id>
        <?supplied-pmid 31710517?>
        <pub-id pub-id-type="pmid">31710517</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Chow</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Tellier</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Vattikuti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Purcell</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>JJ</given-names>
          </name>
        </person-group>
        <article-title>Second-generation PLINK: rising to the challenge of larger and richer datasets</article-title>
        <source>GigaScience.</source>
        <year>2015</year>
        <volume>4</volume>
        <fpage>7</fpage>
        <pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id>
        <pub-id pub-id-type="pmid">25722852</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Genomes Project</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Auton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Durbin</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Garrison</surname>
            <given-names>EP</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>HM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A global reference for human genetic variation</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>526</volume>
        <issue>7571</issue>
        <fpage>68</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
        <pub-id pub-id-type="pmid">26432245</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>MX</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Cherny</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Sham</surname>
            <given-names>PC</given-names>
          </name>
        </person-group>
        <article-title>Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets</article-title>
        <source>Human genetics.</source>
        <year>2012</year>
        <volume>131</volume>
        <issue>5</issue>
        <fpage>747</fpage>
        <lpage>756</lpage>
        <pub-id pub-id-type="doi">10.1007/s00439-011-1118-2</pub-id>
        <?supplied-pmid 22143225?>
        <pub-id pub-id-type="pmid">22143225</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bulik-Sullivan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Finucane</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Anttila</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Gusev</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Day</surname>
            <given-names>FR</given-names>
          </name>
          <name>
            <surname>Loh</surname>
            <given-names>PR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An atlas of genetic correlations across human diseases and traits</article-title>
        <source>Nat Genet.</source>
        <year>2015</year>
        <volume>47</volume>
        <issue>11</issue>
        <fpage>1236</fpage>
        <lpage>1241</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3406</pub-id>
        <?supplied-pmid 26414676?>
        <pub-id pub-id-type="pmid">26414676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McClain</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Constantine</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Henao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tsalik</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>TW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dysregulated transcriptional responses to SARS-CoV-2 in the periphery</article-title>
        <source>Nat Commun.</source>
        <year>2021</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>1079</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-021-21289-y</pub-id>
        <?supplied-pmid 33597532?>
        <pub-id pub-id-type="pmid">33597532</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dobin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Schlesinger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Drenkow</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zaleski</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Batut</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Chaisson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gingeras</surname>
            <given-names>TR</given-names>
          </name>
        </person-group>
        <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
        <source>Bioinformatics.</source>
        <year>2013</year>
        <volume>29</volume>
        <issue>1</issue>
        <fpage>15</fpage>
        <lpage>21</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
        <?supplied-pmid 23104886?>
        <pub-id pub-id-type="pmid">23104886</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Robinson</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Oshlack</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>A scaling normalization method for differential expression analysis of RNA-seq data</article-title>
        <source>Genome Biol.</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>3</issue>
        <fpage>R25</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2010-11-3-r25</pub-id>
        <?supplied-pmid 20196867?>
        <pub-id pub-id-type="pmid">20196867</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ritchie</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Phipson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Law</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
        <source>Nucleic Acids Res</source>
        <year>2015</year>
        <volume>43</volume>
        <issue>7</issue>
        <fpage>e47</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
        <pub-id pub-id-type="pmid">25605792</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <mixed-citation publication-type="other">Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289â300.</mixed-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>Team RC</collab>
        </person-group>
        <source>R: A language and environment for statistical computing</source>
        <year>2020</year>
        <publisher-loc>Vienna</publisher-loc>
        <publisher-name>R Foundation for Statistical Computing</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Allaire</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>McPherson</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <source>Shiny: web application framework for R. 1.5.0 ed</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>RStudio</collab>
        </person-group>
        <source>Shiny Server: Put Shiny Web Apps Online. 1.5.0 ed</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Hipp</surname>
            <given-names>RD</given-names>
          </name>
        </person-group>
        <source>SQLite</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Muller</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wickham</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Falcon</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <source>RSQLite: âSQLiteâ Interface for R. 2.2.1 ed</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Bengtsson</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>A unifying framework for parallel and distributed processing in r using futures</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bodofsky</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Merriman</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Schlesinger</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Advances in our understanding of gout as an auto-inflammatory disease</article-title>
        <source>Semin Arthritis Rheum.</source>
        <year>2020</year>
        <volume>50</volume>
        <issue>5</issue>
        <fpage>1089</fpage>
        <lpage>1100</lpage>
        <pub-id pub-id-type="doi">10.1016/j.semarthrit.2020.06.015</pub-id>
        <?supplied-pmid 32916560?>
        <pub-id pub-id-type="pmid">32916560</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>HW</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>WT</given-names>
          </name>
        </person-group>
        <article-title>ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study</article-title>
        <source>Sci Rep.</source>
        <year>2018</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>3137</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-21425-7</pub-id>
        <?supplied-pmid 29453348?>
        <pub-id pub-id-type="pmid">29453348</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>BY</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>JH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences</article-title>
        <source>Rheumatology (Oxford).</source>
        <year>2012</year>
        <volume>51</volume>
        <issue>4</issue>
        <fpage>715</fpage>
        <lpage>720</lpage>
        <pub-id pub-id-type="doi">10.1093/rheumatology/ker373</pub-id>
        <?supplied-pmid 22179738?>
        <pub-id pub-id-type="pmid">22179738</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Kuo</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>CC</given-names>
          </name>
        </person-group>
        <article-title>Integrative genome-wide association studies of eQTL and GWAS data for gout disease susceptibility</article-title>
        <source>Sci Rep.</source>
        <year>2019</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>4981</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-019-41434-4</pub-id>
        <?supplied-pmid 30899057?>
        <pub-id pub-id-type="pmid">30899057</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xing</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qing</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Mi</surname>
            <given-names>QS</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese</article-title>
        <source>Nat Commun.</source>
        <year>2015</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>7041</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms8041</pub-id>
        <?supplied-pmid 25967671?>
        <pub-id pub-id-type="pmid">25967671</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nakayama</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nakaoka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sakiyama</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shaukat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Toyoda</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kamatani</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yasujima</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yuasa</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shirahama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nakashima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Higashino</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ogata</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kawaguchi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ohkawa</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Danjoh</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Tokumasu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ooyama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kondo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wakai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Stiburkova</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Pavelka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Stamp</surname>
            <given-names>LK</given-names>
          </name>
          <name>
            <surname>Dalbeth</surname>
            <given-names>N</given-names>
          </name>
          <collab>Eurogout Consortium</collab>
          <name>
            <surname>Sakurai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hosoyamada</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fujimori</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yokoo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hosoya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kubo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ooyama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ichida</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shinomiya</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Merriman</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Matsuo</surname>
            <given-names>H</given-names>
          </name>
          <collab>Eurogout Consortium</collab>
        </person-group>
        <article-title>GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes</article-title>
        <source>Ann Rheum Dis</source>
        <year>2017</year>
        <volume>76</volume>
        <issue>5</issue>
        <fpage>869</fpage>
        <lpage>877</lpage>
        <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-209632</pub-id>
        <?supplied-pmid 27899376?>
        <pub-id pub-id-type="pmid">27899376</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nakayama</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nakatochi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kawamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakaoka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Higashino</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Koyama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hishida</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kuriki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ooyama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ooyama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nagase</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hidaka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Matsui</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nishiyama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shimanoe</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Katsuura-Kamano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Takashima</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Shirai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kawaguchi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sugiyama</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nakashima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tsunoda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Danjoh</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hozawa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hosomichi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Toyoda</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kubota</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Stiburkova</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Major</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Merriman</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Kuriyama</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mikami</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Takezaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Matsuo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hosoya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kamatani</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kubo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ichida</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wakai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shinomiya</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Matsuo</surname>
            <given-names>H</given-names>
          </name>
          <collab>Japan Gout Genomics Consortium (Japan Gout)</collab>
        </person-group>
        <article-title>Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients</article-title>
        <source>Ann Rheum Dis</source>
        <year>2020</year>
        <volume>79</volume>
        <issue>5</issue>
        <fpage>657</fpage>
        <lpage>665</lpage>
        <pub-id pub-id-type="doi">10.1136/annrheumdis-2019-216644</pub-id>
        <?supplied-pmid 32238385?>
        <pub-id pub-id-type="pmid">32238385</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sulem</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gudbjartsson</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Helgadottir</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>Helgason</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gudjonsson</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Zanon</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Besenbacher</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bjornsdottir</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Magnusson</surname>
            <given-names>OT</given-names>
          </name>
          <name>
            <surname>Magnusson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hjartarson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Saemundsdottir</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gylfason</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jonasdottir</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Holm</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Karason</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rafnar</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Stefansson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Andreassen</surname>
            <given-names>OA</given-names>
          </name>
          <name>
            <surname>Pedersen</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Pack</surname>
            <given-names>AI</given-names>
          </name>
          <name>
            <surname>de Visser</surname>
            <given-names>MCH</given-names>
          </name>
          <name>
            <surname>Kiemeney</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Geirsson</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Eyjolfsson</surname>
            <given-names>GI</given-names>
          </name>
          <name>
            <surname>Olafsson</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Masson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Jonsson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Thorsteinsdottir</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Jonsdottir</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Stefansson</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Identification of low-frequency variants associated with gout and serum uric acid levels</article-title>
        <source>Nat Genet.</source>
        <year>2011</year>
        <volume>43</volume>
        <issue>11</issue>
        <fpage>1127</fpage>
        <lpage>1130</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.972</pub-id>
        <?supplied-pmid 21983786?>
        <pub-id pub-id-type="pmid">21983786</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matsuo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakaoka</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nakayama</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sakiyama</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chiba</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes</article-title>
        <source>Ann Rheum Dis</source>
        <year>2016</year>
        <volume>75</volume>
        <issue>4</issue>
        <fpage>652</fpage>
        <lpage>659</lpage>
        <pub-id pub-id-type="doi">10.1136/annrheumdis-2014-206191</pub-id>
        <pub-id pub-id-type="pmid">25646370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dehghan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kottgen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Hwang</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Kao</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Rivadeneira</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study</article-title>
        <source>Lancet.</source>
        <year>2008</year>
        <volume>372</volume>
        <issue>9654</issue>
        <fpage>1953</fpage>
        <lpage>1961</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(08)61343-4</pub-id>
        <pub-id pub-id-type="pmid">18834626</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kottgen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Albrecht</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Teumer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vitart</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Krumsiek</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hundertmark</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association analyses identify 18 new loci associated with serum urate concentrations</article-title>
        <source>Nat Genet.</source>
        <year>2013</year>
        <volume>45</volume>
        <issue>2</issue>
        <fpage>145</fpage>
        <lpage>154</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2500</pub-id>
        <?supplied-pmid 23263486?>
        <pub-id pub-id-type="pmid">23263486</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Woodward</surname>
            <given-names>OM</given-names>
          </name>
          <name>
            <surname>Kao</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Nalls</surname>
            <given-names>MA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele</article-title>
        <source>Hum Mol Genet</source>
        <year>2011</year>
        <volume>20</volume>
        <issue>20</issue>
        <fpage>4056</fpage>
        <lpage>4068</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddr307</pub-id>
        <pub-id pub-id-type="pmid">21768215</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kamatani</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kubo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hosono</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Daigo</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association study of hematological and biochemical traits in a Japanese population</article-title>
        <source>Nat Genet.</source>
        <year>2010</year>
        <volume>42</volume>
        <issue>3</issue>
        <fpage>210</fpage>
        <lpage>215</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.531</pub-id>
        <pub-id pub-id-type="pmid">20139978</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boocock</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Leask</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>Y</given-names>
          </name>
          <collab>Asian Genetic Epidemiology Network C</collab>
          <name>
            <surname>Matsuo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kawamura</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control</article-title>
        <source>Hum Mol Genet</source>
        <year>2020</year>
        <volume>29</volume>
        <issue>6</issue>
        <fpage>923</fpage>
        <lpage>943</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddaa013</pub-id>
        <?supplied-pmid 31985003?>
        <pub-id pub-id-type="pmid">31985003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sanna</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Maschio</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Busonero</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Usala</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mulas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dei</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>OrrÃ¹</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Albai</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bandinelli</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schlessinger</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lakatta</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Scuteri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Najjar</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Guralnik</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Naitza</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Crisponi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ferrucci</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Uda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Nagaraja</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts</article-title>
        <source>PLoS Genet.</source>
        <year>2007</year>
        <volume>3</volume>
        <issue>11</issue>
        <fpage>e194</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.0030194</pub-id>
        <?supplied-pmid 17997608?>
        <pub-id pub-id-type="pmid">17997608</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Doring</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gieger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gohlke</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Prokisch</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Coassin</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SLC2A9 influences uric acid concentrations with pronounced sex-specific effects</article-title>
        <source>Nat Genet</source>
        <year>2008</year>
        <volume>40</volume>
        <issue>4</issue>
        <fpage>430</fpage>
        <lpage>436</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.107</pub-id>
        <pub-id pub-id-type="pmid">18327256</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Marten</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Halperin Kuhns</surname>
            <given-names>VL</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wuttke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kirsten</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels</article-title>
        <source>Nat Genet.</source>
        <year>2019</year>
        <volume>51</volume>
        <issue>10</issue>
        <fpage>1459</fpage>
        <lpage>1474</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0504-x</pub-id>
        <?supplied-pmid 31578528?>
        <pub-id pub-id-type="pmid">31578528</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ai</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zalloum</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019)</article-title>
        <source>Expert Opin Ther Pat.</source>
        <year>2019</year>
        <volume>29</volume>
        <issue>11</issue>
        <fpage>871</fpage>
        <lpage>879</lpage>
        <pub-id pub-id-type="doi">10.1080/13543776.2019.1676727</pub-id>
        <?supplied-pmid 31593642?>
        <pub-id pub-id-type="pmid">31593642</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thorleifsson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Holm</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Edvardsson</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Styrkarsdottir</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Gudbjartsson</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Sulem</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Halldorsson</surname>
            <given-names>BV</given-names>
          </name>
          <name>
            <surname>de Vegt</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>d'Ancona</surname>
            <given-names>FCH</given-names>
          </name>
          <name>
            <surname>den Heijer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Franzson</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Christiansen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Alexandersen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rafnar</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kristjansson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sigurdsson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kiemeney</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Bodvarsson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Indridason</surname>
            <given-names>OS</given-names>
          </name>
          <name>
            <surname>Palsson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Thorsteinsdottir</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Stefansson</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density</article-title>
        <source>Nat Genet.</source>
        <year>2009</year>
        <volume>41</volume>
        <issue>8</issue>
        <fpage>926</fpage>
        <lpage>930</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.404</pub-id>
        <?supplied-pmid 19561606?>
        <pub-id pub-id-type="pmid">19561606</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oddsson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sulem</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Helgason</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Edvardsson</surname>
            <given-names>VO</given-names>
          </name>
          <name>
            <surname>Thorleifsson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sveinbjornsson</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Common and rare variants associated with kidney stones and biochemical traits</article-title>
        <source>Nat Commun.</source>
        <year>2015</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>7975</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms8975</pub-id>
        <?supplied-pmid 26272126?>
        <pub-id pub-id-type="pmid">26272126</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Howles</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Wiberg</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Goldsworthy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bayliss</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Gluck</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic variants of calcium and vitamin D metabolism in kidney stone disease</article-title>
        <source>Nat Commun.</source>
        <year>2019</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>5175</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-019-13145-x</pub-id>
        <pub-id pub-id-type="pmid">31729369</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Setoh</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Terao</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Muro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kawaguchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tabara</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nakayama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kosugi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sekine</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mishima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels</article-title>
        <source>Nat Commun.</source>
        <year>2015</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>7754</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms8754</pub-id>
        <?supplied-pmid 26174136?>
        <pub-id pub-id-type="pmid">26174136</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Suhre</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Arnold</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bhagwat</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Cotton</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Engelke</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Raffler</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Connecting genetic risk to disease end points through the human blood plasma proteome</article-title>
        <source>Nat Commun.</source>
        <year>2017</year>
        <volume>8</volume>
        <fpage>14357</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms14357</pub-id>
        <pub-id pub-id-type="pmid">28240269</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Joosten</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Crisan</surname>
            <given-names>TO</given-names>
          </name>
          <name>
            <surname>Azam</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cleophas</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Koenders</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>van de Veerdonk</surname>
            <given-names>FL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1beta and by the induction of endogenous IL-1Ra</article-title>
        <source>Ann Rheum Dis</source>
        <year>2016</year>
        <volume>75</volume>
        <issue>6</issue>
        <fpage>1219</fpage>
        <lpage>1227</lpage>
        <pub-id pub-id-type="doi">10.1136/annrheumdis-2014-206966</pub-id>
        <?supplied-pmid 26174021?>
        <pub-id pub-id-type="pmid">26174021</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Band</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>QS</given-names>
          </name>
          <name>
            <surname>Jostins</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Pirinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kivinen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Jallow</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Imputation-based meta-analysis of severe malaria in three African populations</article-title>
        <source>PLoS Genet.</source>
        <year>2013</year>
        <volume>9</volume>
        <issue>5</issue>
        <fpage>e1003509</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1003509</pub-id>
        <?supplied-pmid 23717212?>
        <pub-id pub-id-type="pmid">23717212</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jallow</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Teo</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Small</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Rockett</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Deloukas</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>TG</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide and fine-resolution association analysis of malaria in West Africa</article-title>
        <source>Nat Genet.</source>
        <year>2009</year>
        <volume>41</volume>
        <issue>6</issue>
        <fpage>657</fpage>
        <lpage>665</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.388</pub-id>
        <?supplied-pmid 19465909?>
        <pub-id pub-id-type="pmid">19465909</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Malaria Genomic Epidemiology N</collab>
        </person-group>
        <article-title>Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania</article-title>
        <source>Nat Commun</source>
        <year>2019</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>5732</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-019-13480-z</pub-id>
        <pub-id pub-id-type="pmid">31844061</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Malaria Genomic Epidemiology</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Band</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Rockett</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Spencer</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Kwiatkowski</surname>
            <given-names>DP</given-names>
          </name>
        </person-group>
        <article-title>A novel locus of resistance to severe malaria in a region of ancient balancing selection</article-title>
        <source>Nature.</source>
        <year>2015</year>
        <volume>526</volume>
        <issue>7572</issue>
        <fpage>253</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="doi">10.1038/nature15390</pub-id>
        <pub-id pub-id-type="pmid">26416757</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ravenhall</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Campino</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sepulveda</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Manjurano</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nadjm</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mtove</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania</article-title>
        <source>PLoS Genet.</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>1</issue>
        <fpage>e1007172</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1007172</pub-id>
        <?supplied-pmid 29381699?>
        <pub-id pub-id-type="pmid">29381699</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Timmann</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Thye</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vens</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>May</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ehmen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sievertsen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Muntau</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ruge</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Loag</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ansong</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Antwi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Asafo-Adjei</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nguah</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Kwakye</surname>
            <given-names>KO</given-names>
          </name>
          <name>
            <surname>Akoto</surname>
            <given-names>AOY</given-names>
          </name>
          <name>
            <surname>Sylverken</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brendel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schuldt</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Loley</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Franke</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Agbenyega</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ziegler</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Horstmann</surname>
            <given-names>RD</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association study indicates two novel resistance loci for severe malaria</article-title>
        <source>Nature.</source>
        <year>2012</year>
        <volume>489</volume>
        <issue>7416</issue>
        <fpage>443</fpage>
        <lpage>446</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11334</pub-id>
        <?supplied-pmid 22895189?>
        <pub-id pub-id-type="pmid">22895189</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Astle</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Elding</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ruklisa</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mann</surname>
            <given-names>AL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The allelic landscape of human blood cell trait variation and links to common complex disease</article-title>
        <source>Cell.</source>
        <year>2016</year>
        <volume>167</volume>
        <issue>5</issue>
        <fpage>1415</fpage>
        <lpage>1429</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.042</pub-id>
        <pub-id pub-id-type="pmid">27863252</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Raffield</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Mousas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sakaue</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Huffman</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Moscati</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations</article-title>
        <source>Cell.</source>
        <year>2020</year>
        <volume>182</volume>
        <issue>5</issue>
        <fpage>1198</fpage>
        <lpage>1213</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2020.06.045</pub-id>
        <pub-id pub-id-type="pmid">32888493</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kichaev</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhatia</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Loh</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Gazal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Burch</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Freund</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Schoech</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pasaniuc</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>Leveraging polygenic functional enrichment to improve GWAS power</article-title>
        <source>Am J Hum Genet.</source>
        <year>2019</year>
        <volume>104</volume>
        <issue>1</issue>
        <fpage>65</fpage>
        <lpage>75</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.11.008</pub-id>
        <?supplied-pmid 30595370?>
        <pub-id pub-id-type="pmid">30595370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fatumo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Carstensen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nashiru</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Gurdasani</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sandhu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kaleebu</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Complimentary methods for multivariate genome-wide association study identify new susceptibility genes for blood cell traits</article-title>
        <source>Front Genet.</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>334</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2019.00334</pub-id>
        <pub-id pub-id-type="pmid">31080455</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Qayyum</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schick</surname>
            <given-names>UM</given-names>
          </name>
          <name>
            <surname>Nalls</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Handsaker</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yanek</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Keating</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Meng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>van Rooij</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kubo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rasmussen-Torvik</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Keller</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Lange</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bottinger</surname>
            <given-names>EP</given-names>
          </name>
          <name>
            <surname>Linderman</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Ruderfer</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Hakonarson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Papanicolaou</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zonderman</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Gottesman</surname>
            <given-names>O</given-names>
          </name>
          <collab>BioBank Japan Project</collab>
          <collab>CHARGE Consortium</collab>
          <name>
            <surname>Thomson</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ziv</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Singleton</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Loos</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Sleiman</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Ganesh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>McCarroll</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Becker</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Lettre</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Reiner</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network</article-title>
        <source>Hum Mol Genet</source>
        <year>2013</year>
        <volume>22</volume>
        <issue>12</issue>
        <fpage>2529</fpage>
        <lpage>2538</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddt087</pub-id>
        <?supplied-pmid 23446634?>
        <pub-id pub-id-type="pmid">23446634</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Scerri</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Quaglieri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zernant</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Matsunami</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Baird</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide analyses identify common variants associated with macular telangiectasia type 2</article-title>
        <source>Nat Genet.</source>
        <year>2017</year>
        <volume>49</volume>
        <issue>4</issue>
        <fpage>559</fpage>
        <lpage>567</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3799</pub-id>
        <?supplied-pmid 28250457?>
        <pub-id pub-id-type="pmid">28250457</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gantner</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Eade</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Handzlik</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Fallon</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Trombley</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bonelli</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Giles</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Harkins-Perry</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Heeren</surname>
            <given-names>TFC</given-names>
          </name>
          <name>
            <surname>Sauer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ideguchi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Baldini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Scheppke</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dorrell</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>Kitano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hart</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nagasaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Badur</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Woods</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Egan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gillies</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Guymer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Eichler</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bahlo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fruttiger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Allikmets</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bernstein</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Metallo</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Friedlander</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Serine and lipid metabolism in macular disease and peripheral neuropathy</article-title>
        <source>N Engl J Med.</source>
        <year>2019</year>
        <volume>381</volume>
        <issue>15</issue>
        <fpage>1422</fpage>
        <lpage>1433</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa1815111</pub-id>
        <?supplied-pmid 31509666?>
        <pub-id pub-id-type="pmid">31509666</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fumagalli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sironi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pozzoli</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Ferrer-Admetlla</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pattini</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution</article-title>
        <source>PLoS Genet.</source>
        <year>2011</year>
        <volume>7</volume>
        <issue>11</issue>
        <fpage>e1002355</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1002355</pub-id>
        <?supplied-pmid 22072984?>
        <pub-id pub-id-type="pmid">22072984</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pittman</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Glover</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ko</surname>
            <given-names>DC</given-names>
          </name>
        </person-group>
        <article-title>The legacy of past pandemics: common human mutations that protect against infectious disease</article-title>
        <source>PLoS Pathog.</source>
        <year>2016</year>
        <volume>12</volume>
        <issue>7</issue>
        <fpage>e1005680</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.ppat.1005680</pub-id>
        <?supplied-pmid 27442518?>
        <pub-id pub-id-type="pmid">27442518</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ahola-Olli</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Wurtz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Havulinna</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Aalto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pitkanen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lehtimaki</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors</article-title>
        <source>Am J Hum Genet.</source>
        <year>2017</year>
        <volume>100</volume>
        <issue>1</issue>
        <fpage>40</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.007</pub-id>
        <?supplied-pmid 27989323?>
        <pub-id pub-id-type="pmid">27989323</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tanikawa</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Urabe</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Matsuo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kubo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tajima</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kamatani</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population</article-title>
        <source>Nat Genet.</source>
        <year>2012</year>
        <volume>44</volume>
        <issue>4</issue>
        <fpage>430</fpage>
        <lpage>434</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.1109</pub-id>
        <?supplied-pmid 22387998?>
        <pub-id pub-id-type="pmid">22387998</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Amundadottir</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Stolzenberg-Solomon</surname>
            <given-names>RZ</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Arslan</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Bueno-de-Mesquita</surname>
            <given-names>HB</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Helzlsouer</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Jacobs</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>LaCroix</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Albanes</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bamlet</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Berg</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Berrino</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bingham</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Buring</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Bracci</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Canzian</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Clavel-Chapelon</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Clipp</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cotterchio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>de Andrade</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duell</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Fox Jr</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Gallinger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gaziano</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Giovannucci</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Goggins</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>GonzÃ¡lez</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Hallmans</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hankinson</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Hassan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Holly</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Hutchinson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jackson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jacobs</surname>
            <given-names>KB</given-names>
          </name>
          <name>
            <surname>Jenab</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kaaks</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Kooperberg</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kurtz</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lynch</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Mandelson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>McWilliams</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Mendelsohn</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Michaud</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Olson</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Overvad</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Peeters</surname>
            <given-names>PHM</given-names>
          </name>
          <name>
            <surname>Rajkovic</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Riboli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Risch</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Shu</surname>
            <given-names>XO</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tobias</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Trichopoulos</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>van den Eeden</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Virtamo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wactawski-Wende</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wolpin</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zeleniuch-Jacquotte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chanock</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Hartge</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hoover</surname>
            <given-names>RN</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer</article-title>
        <source>Nat Genet.</source>
        <year>2009</year>
        <volume>41</volume>
        <issue>9</issue>
        <fpage>986</fpage>
        <lpage>990</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.429</pub-id>
        <?supplied-pmid 19648918?>
        <pub-id pub-id-type="pmid">19648918</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shah</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Henry</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Roselli</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sveinbjornsson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fatemifar</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure</article-title>
        <source>Nat Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>163</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-019-13690-5</pub-id>
        <?supplied-pmid 31919418?>
        <pub-id pub-id-type="pmid">31919418</pub-id>
      </element-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <mixed-citation publication-type="other">Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis. 2020. 10.1093/cid/ciaa1150.</mixed-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <mixed-citation publication-type="other">Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15â27.</mixed-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Canis</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Anzengruber</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Garenaux</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Feichtinger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Benamara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Scheiflinger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Savoy</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Reipert</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Malisauskas</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>In-depth comparison of N-glycosylation of human plasma-derived factor VIII and different recombinant products: from structure to clinical implications</article-title>
        <source>J Thromb Haemost.</source>
        <year>2018</year>
        <volume>16</volume>
        <issue>8</issue>
        <fpage>1592</fpage>
        <lpage>1603</lpage>
        <pub-id pub-id-type="doi">10.1111/jth.14204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matsui</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Titani</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mizuochi</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures</article-title>
        <source>J Biol Chem.</source>
        <year>1992</year>
        <volume>267</volume>
        <issue>13</issue>
        <fpage>8723</fpage>
        <lpage>8731</lpage>
        <pub-id pub-id-type="doi">10.1016/S0021-9258(19)50338-6</pub-id>
        <?supplied-pmid 1577715?>
        <pub-id pub-id-type="pmid">1577715</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sodetz</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Paulson</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>McKee</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human factor VIII/von Willebrand factor</article-title>
        <source>J Biol Chem.</source>
        <year>1979</year>
        <volume>254</volume>
        <issue>21</issue>
        <fpage>10754</fpage>
        <lpage>10760</lpage>
        <pub-id pub-id-type="doi">10.1016/S0021-9258(19)86586-9</pub-id>
        <?supplied-pmid 315409?>
        <pub-id pub-id-type="pmid">315409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gallinaro</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cattini</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Sztukowska</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Padrini</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sartorello</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pontara</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor</article-title>
        <source>Blood.</source>
        <year>2008</year>
        <volume>111</volume>
        <issue>7</issue>
        <fpage>3540</fpage>
        <lpage>3545</lpage>
        <pub-id pub-id-type="doi">10.1182/blood-2007-11-122945</pub-id>
        <pub-id pub-id-type="pmid">18245665</pub-id>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fujimura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nishiyama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tsujiuchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Narita</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Matsui</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Titani</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Katayama</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>FI</given-names>
          </name>
          <name>
            <surname>Yoshioka</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ABO blood group genotype and plasma von Willebrand factor in normal individuals</article-title>
        <source>Vox Sang.</source>
        <year>1995</year>
        <volume>68</volume>
        <issue>4</issue>
        <fpage>236</fpage>
        <lpage>240</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1423-0410.1995.tb02579.x</pub-id>
        <?supplied-pmid 7660643?>
        <pub-id pub-id-type="pmid">7660643</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Albanez</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ogiwara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Michels</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hopman</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Grabell</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms</article-title>
        <source>J Thromb Haemost.</source>
        <year>2016</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>953</fpage>
        <lpage>963</lpage>
        <pub-id pub-id-type="doi">10.1111/jth.13294</pub-id>
        <?supplied-pmid 26875505?>
        <pub-id pub-id-type="pmid">26875505</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Song</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Campos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bolgiano</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Houck</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chambless</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Folsom</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Couper</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Boerwinkle</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>JF</given-names>
          </name>
        </person-group>
        <article-title>Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects</article-title>
        <source>PLoS One.</source>
        <year>2015</year>
        <volume>10</volume>
        <issue>8</issue>
        <fpage>e0132626</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0132626</pub-id>
        <?supplied-pmid 26244499?>
        <pub-id pub-id-type="pmid">26244499</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murray</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Post</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Post</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells</article-title>
        <source>J Clin Pathol.</source>
        <year>2020</year>
        <volume>73</volume>
        <issue>6</issue>
        <fpage>347</fpage>
        <lpage>349</lpage>
        <pub-id pub-id-type="doi">10.1136/jclinpath-2019-206182</pub-id>
        <?supplied-pmid 31662441?>
        <pub-id pub-id-type="pmid">31662441</pub-id>
      </element-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mangalmurti</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>Cytokine storms: understanding COVID-19</article-title>
        <source>Immunity.</source>
        <year>2020</year>
        <volume>53</volume>
        <issue>1</issue>
        <fpage>19</fpage>
        <lpage>25</lpage>
        <pub-id pub-id-type="doi">10.1016/j.immuni.2020.06.017</pub-id>
        <?supplied-pmid 32610079?>
        <pub-id pub-id-type="pmid">32610079</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <mixed-citation publication-type="other">Katz DH, Tahir UA, Ngo D, Benson MD, Bick AG, Pampana A, et al. Proteomic profiling in biracial cohorts implicates DC-SIGN as a mediator of genetic risk in COVID-19. medRxiv. 2020. 10.1101/2020.06.09.20125690.</mixed-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <mixed-citation publication-type="other">Amraie R, Napoleon MA, Yin W, Berrigan J, Suder E, Zhao G, et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. bioRxiv. 2020. 10.1101/2020.06.22.165803.</mixed-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <mixed-citation publication-type="other">Gao C, Zeng J, Jia N, Stavenhagen K, Matsumoto Y, Zhang H, et al. SARS-CoV-2 spike protein interacts with multiple innate immune receptors. bioRxiv. 2020. 10.1101/2020.07.29.227462.</mixed-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fingerlin</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Peljto</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Steele</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Loyd</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Cosgrove</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Lynch</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Groshong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Collard</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Wolters</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Bradford</surname>
            <given-names>WZ</given-names>
          </name>
          <name>
            <surname>Kossen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Seiwert</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>du Bois</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Devine</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Gudmundsson</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Isaksson</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Kaminski</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>KF</given-names>
          </name>
          <name>
            <surname>Lancaster</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Cogan</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Mason</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Maher</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Molyneaux</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>AU</given-names>
          </name>
          <name>
            <surname>Moffatt</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Selman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pardo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Crapo</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Make</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Regan</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Walek</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Daniel</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Kamatani</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zelenika</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>McKean</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pedersen</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Talbert</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kidd</surname>
            <given-names>RN</given-names>
          </name>
          <name>
            <surname>Markin</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Beckman</surname>
            <given-names>KB</given-names>
          </name>
          <name>
            <surname>Lathrop</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schwarz</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis</article-title>
        <source>Nat Genet.</source>
        <year>2013</year>
        <volume>45</volume>
        <issue>6</issue>
        <fpage>613</fpage>
        <lpage>620</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2609</pub-id>
        <?supplied-pmid 23583980?>
        <pub-id pub-id-type="pmid">23583980</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Alwalid</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study</article-title>
        <source>Lancet Infect Dis</source>
        <year>2020</year>
        <volume>20</volume>
        <issue>4</issue>
        <fpage>425</fpage>
        <lpage>434</lpage>
        <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30086-4</pub-id>
        <pub-id pub-id-type="pmid">32105637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ojo</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Balogun</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>OT</given-names>
          </name>
          <name>
            <surname>Ojo</surname>
            <given-names>OS</given-names>
          </name>
        </person-group>
        <article-title>Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies</article-title>
        <source>Pulm Med.</source>
        <year>2020</year>
        <volume>2020</volume>
        <fpage>6175964</fpage>
        <pub-id pub-id-type="doi">10.1155/2020/6175964</pub-id>
        <pub-id pub-id-type="pmid">32850151</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <mixed-citation publication-type="other">Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591(7848):92â8.</mixed-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Consortium</surname>
            <given-names>GT</given-names>
          </name>
        </person-group>
        <article-title>Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>
        <source>Science.</source>
        <year>2015</year>
        <volume>348</volume>
        <issue>6235</issue>
        <fpage>648</fpage>
        <lpage>660</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1262110</pub-id>
        <pub-id pub-id-type="pmid">25954001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raj</surname>
            <given-names>VS</given-names>
          </name>
          <name>
            <surname>Mou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Smits</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Dekkers</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Dijkman</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</article-title>
        <source>Nature.</source>
        <year>2013</year>
        <volume>495</volume>
        <issue>7440</issue>
        <fpage>251</fpage>
        <lpage>254</lpage>
        <pub-id pub-id-type="doi">10.1038/nature12005</pub-id>
        <?supplied-pmid 23486063?>
        <pub-id pub-id-type="pmid">23486063</pub-id>
      </element-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Okondo</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Sridharan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Go</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Chui</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>MS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis</article-title>
        <source>Nat Chem Biol.</source>
        <year>2017</year>
        <volume>13</volume>
        <issue>1</issue>
        <fpage>46</fpage>
        <lpage>53</lpage>
        <pub-id pub-id-type="doi">10.1038/nchembio.2229</pub-id>
        <pub-id pub-id-type="pmid">27820798</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Okondo</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Taabazuing</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Chui</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Poplawski</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Bachovchin</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome</article-title>
        <source>Cell Chem Biol.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>3</issue>
        <fpage>262</fpage>
        <lpage>267</lpage>
        <pub-id pub-id-type="doi">10.1016/j.chembiol.2017.12.013</pub-id>
        <?supplied-pmid 29396289?>
        <pub-id pub-id-type="pmid">29396289</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhong</surname>
            <given-names>FL</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Teo</surname>
            <given-names>DET</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>KY</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Harapas</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Sobota</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Au</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Hopkins</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>D'Osualdo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Reed</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Connolly</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Masters</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Reversade</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding</article-title>
        <source>J Biol Chem.</source>
        <year>2018</year>
        <volume>293</volume>
        <issue>49</issue>
        <fpage>18864</fpage>
        <lpage>18878</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.RA118.004350</pub-id>
        <?supplied-pmid 30291141?>
        <pub-id pub-id-type="pmid">30291141</pub-id>
      </element-citation>
    </ref>
    <ref id="CR101">
      <label>101.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shah</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>N-GlycositeAtlas: a database resource for mass spectrometry-based human N-linked glycoprotein and glycosylation site mapping</article-title>
        <source>Clin Proteomic.</source>
        <year>2019</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>35</fpage>
        <pub-id pub-id-type="doi">10.1186/s12014-019-9254-0</pub-id>
      </element-citation>
    </ref>
    <ref id="CR102">
      <label>102.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lauc</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Essafi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Huffman</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Hayward</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Knezevic</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kattla</surname>
            <given-names>JJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation</article-title>
        <source>PLoS Genet.</source>
        <year>2010</year>
        <volume>6</volume>
        <issue>12</issue>
        <fpage>e1001256</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1001256</pub-id>
        <?supplied-pmid 21203500?>
        <pub-id pub-id-type="pmid">21203500</pub-id>
      </element-citation>
    </ref>
    <ref id="CR103">
      <label>103.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sharapov</surname>
            <given-names>SZ</given-names>
          </name>
          <name>
            <surname>Tsepilov</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Klaric</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Mangino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Thareja</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Shadrina</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Simurina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dagostino</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dmitrieva</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vilaj</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vuckovic</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pavic</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Stambuk</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Trbojevic-Akmacic</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kristic</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Simunovic</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Momcilovic</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Doherty</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dunlop</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Farrington</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Pucic-Bakovic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gieger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Allegri</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Louis</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Georges</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Suhre</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Spector</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>FMK</given-names>
          </name>
          <name>
            <surname>Lauc</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Aulchenko</surname>
            <given-names>YS</given-names>
          </name>
        </person-group>
        <article-title>Defining the genetic control of human blood plasma N-glycome using genome-wide association study</article-title>
        <source>Hum Mol Genet</source>
        <year>2019</year>
        <volume>28</volume>
        <issue>12</issue>
        <fpage>2062</fpage>
        <lpage>2077</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddz054</pub-id>
        <?supplied-pmid 31163085?>
        <pub-id pub-id-type="pmid">31163085</pub-id>
      </element-citation>
    </ref>
    <ref id="CR104">
      <label>104.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huffman</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Knezevic</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vitart</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Kattla</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Adamczyk</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Novokmet</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults</article-title>
        <source>Hum Mol Genet</source>
        <year>2011</year>
        <volume>20</volume>
        <issue>24</issue>
        <fpage>5000</fpage>
        <lpage>5011</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/ddr414</pub-id>
        <?supplied-pmid 21908519?>
        <pub-id pub-id-type="pmid">21908519</pub-id>
      </element-citation>
    </ref>
    <ref id="CR105">
      <label>105.</label>
      <mixed-citation publication-type="other">Sharapov SZ, Shadrina AS, Tsepilov YA, Elgaeva EE, Tiys ES, Feoktistova SG, et al. Replication of fifteen loci involved in human plasma protein N-glycosylation in 4,802 samples from four cohorts. Glycobiology. 2021;31(2):82â8.</mixed-citation>
    </ref>
    <ref id="CR106">
      <label>106.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>George</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Wells</surname>
            <given-names>AU</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>RG</given-names>
          </name>
        </person-group>
        <article-title>Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy</article-title>
        <source>Lancet Respir Med.</source>
        <year>2020</year>
        <volume>8</volume>
        <issue>8</issue>
        <fpage>807</fpage>
        <lpage>815</lpage>
        <pub-id pub-id-type="doi">10.1016/S2213-2600(20)30225-3</pub-id>
        <pub-id pub-id-type="pmid">32422178</pub-id>
      </element-citation>
    </ref>
    <ref id="CR107">
      <label>107.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seifirad</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Pirfenidone: a novel hypothetical treatment for COVID-19</article-title>
        <source>Med Hypotheses.</source>
        <year>2020</year>
        <volume>144</volume>
        <fpage>110005</fpage>
        <pub-id pub-id-type="doi">10.1016/j.mehy.2020.110005</pub-id>
        <pub-id pub-id-type="pmid">32575019</pub-id>
      </element-citation>
    </ref>
    <ref id="CR108">
      <label>108.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ferrara</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Granata</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pelliccia</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>La Porta</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Vitiello</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2: anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?</article-title>
        <source>Eur J Clin Pharmacol.</source>
        <year>2020</year>
        <volume>76</volume>
        <issue>11</issue>
        <fpage>1615</fpage>
        <lpage>1618</lpage>
        <pub-id pub-id-type="doi">10.1007/s00228-020-02947-4</pub-id>
        <pub-id pub-id-type="pmid">32594204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR109">
      <label>109.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Wickham</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Ggplot2: elegant graphics for data analysis</source>
        <year>2009</year>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Springer</publisher-name>
        <fpage>212</fpage>
      </element-citation>
    </ref>
    <ref id="CR110">
      <label>110.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Wilkins</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <source>gggenes: Draw Gene Arrow Maps in âggplot2â. R package version 0.4.1</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR111">
      <label>111.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Pedersen</surname>
            <given-names>TL</given-names>
          </name>
        </person-group>
        <source>tidygraph: A tidy API for graph manipulation. R package version 1.2.0</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR112">
      <label>112.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Briatte</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <source>ggnetwork: geometries to plot networks with âggplot2â. R package version 0.5.8</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR113">
      <label>113.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Eils</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schlesner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brors</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>circlize implements and enhances circular visualization in R</article-title>
        <source>Bioinformatics.</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>19</issue>
        <fpage>2811</fpage>
        <lpage>2812</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu393</pub-id>
        <?supplied-pmid 24930139?>
        <pub-id pub-id-type="pmid">24930139</pub-id>
      </element-citation>
    </ref>
    <ref id="CR114">
      <label>114.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kassambara</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <source>ggpubr: âggplot2â based publication ready plots. R package version 0.4.0</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR115">
      <label>115.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <source>DT: A Wrapper of the JavaScript Library âDataTablesâ. R package version 0.17</source>
        <year>2021</year>
      </element-citation>
    </ref>
    <ref id="CR116">
      <label>116.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Sievert</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <source>Interactive web-based data visualization with R, plotly, and shiny</source>
        <year>2020</year>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>CRC Press, Taylor and Francis Group</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR117">
      <label>117.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Galili</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>O'Callaghan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sidi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sievert</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>heatmaply: an R package for creating interactive cluster heatmaps for online publishing</article-title>
        <source>Bioinformatics.</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>9</issue>
        <fpage>1600</fpage>
        <lpage>1602</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx657</pub-id>
        <pub-id pub-id-type="pmid">29069305</pub-id>
      </element-citation>
    </ref>
    <ref id="CR118">
      <label>118.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <source>promises: abstractions for promise-based asynchronous programming. R package v1.1.1</source>
        <year>2020</year>
      </element-citation>
    </ref>
  </ref-list>
</back>
